Asthma and opportunity respiratory infection

ASTHMA_OPPORTUNIST_INFECTIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions J10_ASTHMA	63265
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints MYCOBLUNGATYPICA ABPA J10_BRONCHIECTASIS	1745
6. Filter based on genotype QC (FinnGen only)	1699

Control definitions (FinnGen only)

Control conditions: not J10_ASTHMA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_OPPORTUNIST_INFECTIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!J10_ASTHMA
SEX
INCLUDE	MYCOBLUNGATYPICA\|ABPA\|J10_BRONCHIECTASIS
PRE_CONDITIONS
CONDITIONS	J10_ASTHMA
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma and opportunity respiratory infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8980	5319	3578
Only index persons	7807	4794	3013
Unadjusted period prevalence (%)
Whole population	0.13	0.15	0.10
Only index persons	0.15	0.18	0.12
Median age at first event (years)
Whole population	63.65	63.39	64.10
Only index persons	63.61	63.28	64.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1699	1031	668
Unadjusted period prevalence (%)	0.34	0.37	0.31
Median age at first event (years)	63.09	61.48	65.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1745: Matched controls
17450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.7

316.2

558

1009

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

12.7

314.4

333

317

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

8.3

311.4

496

801

J18.9

ICD-10 Finland

Pneumonia, unspecified

8.9

307.7

1125

2968

R03BB01

ATC

ipratropium bromide; inhalant

17.1

307.7

322

228

R96

ICPC

Asthma

20.1

307.7

557

397

R03AK06

ATC

salmeterol and fluticasone; inhalant

33.0

307.7

1067

794

R03BA02

ATC

budesonide; inhalant

12.9

307.7

820

1120

R03AK07

ATC

formoterol and budesonide; inhalant

9.0

307.7

771

1404

J01MA14

ATC

moxifloxacin; systemic

14.3

307.7

689

761

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

37.3

307.7

329

108

J45.1

ICD-10 Finland

Nonallergic asthma

425.3

307.7

840

R03AC03

ATC

terbutaline; inhalant

9.8

307.7

600

885

R03AK08

ATC

formoterol and beclometasone; inhalant

55.9

307.7

454

109

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

8.0

307.7

840

1820

J45.8

ICD-10 Finland

Mixed asthma

402.2

307.7

327

J45

ICD-10 Finland

Asthma

28.8

307.7

626

333

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

158.1

307.7

184

R03AC02

ATC

salbutamol; inhalant

32.7

307.7

1649

6010

XG474

NOMESCO Finland

Exhalation nntrogen oxide

36.8

307.7

217

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

14.0

307.7

367

325

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

18.5

307.7

530

403

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

21.5

307.7

280

154

J47

ICD-10 Finland

Bronchiectasis

1052.5

307.7

1523

113

R03DA04

ATC

theophylline; systemic, rectal

31.2

307.7

537

245

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

9.6

307.7

558

814

J45.0

ICD-10 Finland

Predominantly allergic asthma

256.0

307.7

748

H02AB06

ATC

prednisolone; systemic

18.0

307.7

1561

5590

R03AC12

ATC

salmeterol; inhalant

60.5

307.7

512

119

R03AK11

ATC

formoterol and fluticasone; inhalant

38.4

307.7

251

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

114.3

307.7

1443

700

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

18.6

307.7

296

190

R03BA01

ATC

beclometasone; inhalant

13.8

307.7

718

841

UGC12

NOMESCO Finland

Flexible bronchoscopy

15.5

307.7

668

670

R03BA08

ATC

ciclesonide; inhalant

14.0

307.7

475

454

R03AC13

ATC

formoterol; inhalant

28.6

307.7

383

170

J46

ICD-10 Finland

Status asthmaticus

309.1

307.7

347

R03DC03

ATC

montelukast; oral

30.8

307.7

1075

863

J45.9

ICD-10 Finland

Asthma, unspecified

300.4

307.7

1532

408

R03BB04

ATC

tiotropium bromide; inhalant

38.8

307.7

1051

656

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

16.0

307.7

332

253

R03BA05

ATC

fluticasone; inhalant

15.2

307.7

935

1228

H02AB04

ATC

methylprednisolone; systemic

6.9

300.5

602

1234

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

9.7

292.8

385

493

R03DC01

ATC

zafirlukast; oral

49.1

289.1

169

H02AB07

ATC

prednisone; oral

6.6

282.2

591

1258

J01FA06

ATC

roxithromycin; oral

5.9

278.8

1202

4769

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

51.1

266.0

154

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

63.8

254.6

141

TDM10

NOMESCO Finland

Puncture of maxillary antrum

14.1

251.5

243

198

J01MA12

ATC

levofloxacin; systemic

5.3

249.1

735

2098

51899

ICD-8 Finland

Bronchiectasis

104.4

244.2

126

R03AK03

ATC

[U] fenoterol and ipratropium bromide

10.0

237.7

295

347

TGC00

NOMESCO Finland

Bronchial lavation

14.6

236.4

222

172

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

10.9

232.2

269

288

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

5.4

227.1

1306

6170

R04.2

ICD-10 Finland

Haemoptysis

11.4

217.3

241

242

XG410

NOMESCO Finland

Flow-volume spirometry

10.5

202.3

238

259

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

12.6

200.4

206

184

J01FA09

ATC

clarithromycin; systemic

4.3

195.2

863

3254

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

8.2

193.6

282

401

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.2

193.2

202

185

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.8

193.0

1288

6489

49300

ICD-8 Finland

Asthma, bronchiale

+∞

192.3

181

GD1AD

NOMESCO Finland

Thorax CT examination

7.2

187.7

312

513

R01AD08

ATC

fluticasone; nasal

4.2

187.5

774

2764

J01FA10

ATC

azithromycin; systemic

4.6

183.2

1289

6644

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.3

181.0

294

471

J01FA15

ATC

telithromycin; oral

5.8

174.5

369

767

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

48.7

173.1

101

R06.0

ICD-10 Finland

Dyspnoea

4.0

172.5

810

3130

R81

ICPC

Pneumonia

9.5

166.2

209

247

R02

ICPC

Shortness of breath/dyspnoea

4.8

165.9

470

1251

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.8

164.8

285

486

R01AD09

ATC

mometasone; nasal

3.7

154.5

1037

4972

J01AA02

ATC

doxycycline; systemic

11.4

153.0

1663

11180

J20

ICD-10 Finland

Acute bronchitis

5.2

150.4

366

855

J32.4

ICD-10 Finland

Chronic pansinusitis

25.0

149.2

106

XQ800

NOMESCO Finland

Prick test

6.9

147.7

247

405

R05

ICD-10 Finland

Cough

3.8

145.7

632

2270

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.7

136.7

204

295

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

19.3

134.9

107

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

8.8

126.4

166

206

R01AD05

ATC

budesonide; nasal

5.5

125.3

271

567

A07AA02

ATC

nystatin; oral

5.6

125.2

261

528

R01AD01

ATC

beclometasone; nasal

4.0

123.7

441

1368

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

121.3

115

A01AB09

ATC

miconazole; local oral

4.7

119.6

314

773

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

9.2

117.8

149

176

R05

ICPC

Cough

3.3

115.8

643

2639

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.4

115.4

567

2160

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

8.2

112.6

157

209

XG405

NOMESCO Finland

Education on PEF monitoring

18.7

111.0

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.7

109.7

144

178

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

11.2

105.7

114

108

R03BC03

ATC

nedocromil; inhalant

5.2

105.5

240

522

J33.0

ICD-10 Finland

Polyp of nasal cavity

9.7

104.8

126

139

J31.0

ICD-10 Finland

Chronic rhinitis

4.9

104.7

258

600

J96.1

ICD-10 Finland

Chronic respiratory failure

9.9

102.1

121

131

R06AE07

ATC

cetirizine; oral

2.9

101.1

930

4965

R06.2

ICD-10 Finland

Wheezing

7.2

100.1

155

232

WW200

NOMESCO Finland

Immunization

9.1

99.9

126

148

R01AD58

ATC

fluticasone, combinations; nasal

3.2

98.5

515

2012

J42

ICD-10 Finland

Unspecified chronic bronchitis

15.4

96.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.8

95.8

879

4649

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

44.5

94.0

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

169.2

92.1

J01MA02

ATC

ciprofloxacin; systemic

2.7

91.5

921

5069

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

52.5

88.7

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

52.5

88.7

Z3231

NOMESCO Finland

Registered nurse

2.8

87.9

666

3161

A03

ICPC

Fever

3.3

84.5

380

1344

R01BA52

ATC

pseudoephedrine, combinations; oral

2.7

83.6

680

3329

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.8

83.3

603

2782

R03BB07

ATC

umeclidinium bromide; inhalant

22.5

82.9

R01AD12

ATC

fluticasone furoate; nasal

2.7

81.7

613

2876

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.2

81.6

242

646

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

79.8

R06AX27

ATC

desloratadine; oral

2.8

79.3

554

2499

Z3226

NOMESCO Finland

Physiotherapist

2.9

77.8

478

2013

R28

ICPC

Limited function/disability (R)

11.3

76.9

J33.8

ICD-10 Finland

Other polyp of sinus

10.8

75.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

75.5

249

716

R03BB02

ATC

oxitropium bromide; inhalant

24.2

75.4

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

388.7

75.4

Z01.8

ICD-10 Finland

Other specified special examinations

2.7

74.7

551

2544

J01DA06

ATC

[U] cefuroxime

3.1

73.6

371

1395

R05CB01

ATC

acetylcysteine; inhalant, oral

10.2

73.6

R03BC01

ATC

cromoglicic acid; inhalant

15.9

72.8

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

8.6

72.8

116

J01CA04

ATC

amoxicillin; systemic

3.5

72.3

1520

11494

R95

ICPC

Chron obstructive pulmonary disease

6.7

71.9

118

187

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

70.4

857

4971

H02AB09

ATC

hydrocortisone; systemic

7.4

70.4

105

150

A01AB04

ATC

amphotericin B; local oral

4.7

69.0

172

400

C03CA01

ATC

furosemide; systemic

2.4

68.6

781

4384

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

9.8

67.3

A02BC05

ATC

esomeprazole; systemic

2.4

67.1

873

5181

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

23.5

66.3

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

63.9

423

1830

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

62.4

301

1096

J02AC01

ATC

fluconazole; systemic

2.3

61.9

778

4505

J01DA08

ATC

[U] cefaclor

3.5

61.9

238

754

R50.9

ICD-10 Finland

Fever, unspecified

2.8

61.9

367

1498

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

59.7

C01CA24

ATC

epinephrine; parenteral

4.6

59.3

150

352

A02BC02

ATC

pantoprazole; systemic

2.6

59.3

1348

9953

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

11.7

58.9

J01DC02

ATC

cefuroxime; systemic

4.5

58.9

154

371

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

7.4

58.8

123

J01GB01

ATC

tobramycin; inhalant, parenteral

307.3

58.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

5.4

58.5

119

232

SPAT1325

SPAT

Vaccination

2.3

58.1

778

4593

R74

ICPC

Upper respiratory infection acute

2.4

57.3

546

2788

R06AX13

ATC

loratadine; oral

2.9

57.1

307

1185

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

56.6

J15.8

ICD-10 Finland

Other bacterial pneumonia

15.2

55.5

R4110

NOMESCO Finland

Physiotherapy

2.3

55.0

620

3392

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.3

54.4

546

2842

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

12.1

54.3

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

53.9

512

2601

ZXA10

NOMESCO Finland

Bilateral

2.4

53.6

468

2289

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

53.6

663

3761

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

10.3

53.3

J01DB01

ATC

cefalexin; oral

2.9

53.2

1509

11991

R06AE09

ATC

levocetirizine; oral

2.9

52.5

294

1156

A02BC01

ATC

omeprazole; systemic

2.2

52.5

611

3375

XG466

NOMESCO Finland

Sleep oxymetry

5.7

51.8

182

M05BA04

ATC

alendronic acid; oral

2.9

51.2

286

1122

J01DA01

ATC

[U] cefalexin

2.2

50.8

1168

8368

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.8

50.6

164

462

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

6.7

50.1

126

R78

ICPC

Acute bronchitis/bronchiolitis

6.7

50.1

126

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

12.2

49.8

R06AX26

ATC

fexofenadine; oral

3.9

49.3

155

427

R06AX22

ATC

ebastine; oral

2.6

49.3

341

1491

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

49.2

406

1927

J43.9

ICD-10 Finland

Emphysema, unspecified

7.8

48.6

R29

ICPC

Respiratory symptom/complaint other

3.6

48.3

175

531

49099

ICD-8 Finland

Bronchitis, unspecified

12.3

48.1

G47.3

ICD-10 Finland

Sleep apnoea

2.4

47.6

437

2171

N02AX02

ATC

tramadol; systemic, rectal

2.1

47.2

859

5576

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

47.1

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

47.1

DHB20

NOMESCO Finland

Polypectomy of internal nose

8.8

46.6

UDM02

NOMESCO Finland

Sinoscopy

6.4

46.6

129

4222

FHL

Endonasal etmoidectomy

17.6

46.4

S01GX01

ATC

cromoglicic acid; ophthalmic

2.4

46.0

380

1800

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

45.8

291

1217

Z2221

NOMESCO Finland

Medical doctor

2.2

45.2

562

3152

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.3

45.2

121

296

H65.3

ICD-10 Finland

Chronic mucoid otitis media

7.5

44.3

A02BC03

ATC

lansoprazole; oral

2.1

44.2

621

3643

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.7

44.0

154

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

43.1

251

1002

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

43.0

368

1765

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

8.8

42.8

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

14.9

42.6

H65.2

ICD-10 Finland

Chronic serous otitis media

8.4

42.5

R05FB02

ATC

cough suppressants and expectorants; systemic

2.0

42.2

762

4874

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

12.7

41.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.1

41.6

192

674

1240

FHL

Bronchoscopy

8.9

41.5

J01FF01

ATC

clindamycin; systemic

2.1

40.5

545

3128

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

15.7

39.2

R99

ICPC

Respiratory disease other

5.9

39.1

124

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

107.6

38.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.0

38.5

119

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

14.3

38.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.8

38.1

187

120

Kela drug reimbursment

Hypogammaglobulinaemia

73.3

38.1

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

86.1

37.9

J30.3

ICD-10 Finland

Other allergic rhinitis

5.2

37.8

161

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

51.3

37.7

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

7.0

37.0

A02BA02

ATC

ranitidine; systemic

2.1

36.9

436

2370

WZC30

NOMESCO Finland

Teaching

2.3

36.8

343

1697

SPAT1254

SPAT

Administration of medicine

2.3

36.6

342

1692

J01XB01

ATC

colistin; inhalant, parenteral

364.6

36.1

R01AD11

ATC

triamcinolone; nasal

2.9

36.1

189

711

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

188.9

35.9

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

14.0

35.7

J98.1

ICD-10 Finland

Pulmonary collapse

11.4

35.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.2

35.3

144

4224

FHL

Endonasal anthrostomy

10.5

35.2

R05FA02

ATC

opium derivatives and expectorants; systemic

1.9

35.0

762

5097

J37.0

ICD-10 Finland

Chronic laryngitis

4.2

34.9

235

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

34.8

333

1661

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

6.4

34.8

A46

ICD-10 Finland

Erysipelas

2.2

34.1

325

1618

R24

ICPC

Haemoptysis

10.8

34.1

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

13.6

34.0

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

8.9

33.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

33.7

583

3610

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

33.4

804

5525

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

9.7

33.3

Z2446

NOMESCO Finland

Social worker

3.1

33.2

151

524

N03AX16

ATC

[U] pregabalin

2.0

32.9

476

2769

E0000UV, ,

ATC

1.8

32.8

751

5075

J01DC04

ATC

cefaclor; oral

7.8

32.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

32.2

409

2269

Z71.8

ICD-10 Finland

Other specified counselling

1.9

32.0

545

3345

B05XA03

ATC

sodium chloride; parenteral

168.1

31.8

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

48.5

31.6

R03AC18

ATC

indacaterol; inhalant

10.5

31.6

C07AB07

ATC

bisoprolol; oral

1.8

31.6

988

7305

R49.08

ICD-10 Finland

Other specified dysphonia

5.0

31.5

143

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.0

31.0

143

500

ZXE00

NOMESCO Finland

One hour or less

1.8

31.0

716

4828

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

4.2

30.9

212

J01FA01

ATC

erythromycin; systemic

2.4

30.8

247

1140

4226

FHL

Posterior radical surgery and possible etmoidectomy

9.7

30.7

Y0499

ICD-8 Finland

Investigation of respiratory system

8.3

30.4

R05CA10

ATC

expectorants - combinations

4.9

30.3

144

WX892

NOMESCO Finland

Monitored bed care

2.7

30.3

182

733

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

30.1

223

992

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

29.9

329

1727

SPAT1255

SPAT

Intravenous administration of medicine

2.7

29.7

170

668

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

29.6

194

815

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.7

29.3

152

N02BE01

ATC

paracetamol; systemic, rectal

2.6

29.3

1594

13985

R01AC01

ATC

cromoglicic acid; nasal

4.2

28.8

192

R60.0

ICD-10 Finland

Localized oedema

2.2

28.8

280

1398

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

6.5

28.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.1

28.0

192

B37.0

ICD-10 Finland

Candidal stomatitis

7.9

27.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

27.3

328

1773

48609

ICD-8 Finland

Pneumonia, unspecified

6.9

27.2

N03AX12

ATC

[U] gabapentin; oral

2.0

27.1

334

1822

J96.0

ICD-10 Finland

Acute respiratory failure

6.1

26.9

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

32.4

26.9

SPAT1263

SPAT

Sampling

1.7

26.9

770

5461

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

76.4

26.8

ZX120

NOMESCO Finland

Intravenous

2.3

26.7

214

984

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

26.5

402

2353

J02AC03

ATC

voriconazole; systemic

34.6

26.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

26.3

709

4935

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

26.3

214

991

L28

ICPC

Limited function/disability (L)

1.9

26.3

399

2337

S81.0

ICD-10 Finland

Open wound of knee

5.9

26.3

R05CB03

ATC

carbocisteine; oral

4.4

26.2

158

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

26.0

252

1254

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.6

25.8

A31.9

ICD-10 Finland

Mycobacterial infection, unspecified

137.1

25.7

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.6

25.6

252

R49.01

ICD-10 Finland

Functional dysphonia

4.0

25.6

196

RK110, ,

NOMESCO Finland

8.8

25.4

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

25.1

R03CC02

ATC

salbutamol; systemic

4.0

25.0

190

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

9.8

25.0

R05CB02

ATC

bromhexine; systemic

5.2

24.8

100

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

6.6

24.8

R09.3

ICD-10 Finland

Abnormal sputum

6.1

24.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

24.7

838

6178

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

24.6

620

4215

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

24.5

294

1583

SPAT1058

SPAT

PEF monitoring instruction

2.5

24.5

162

682

RK320, ,

NOMESCO Finland

8.5

24.0

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

24.0

518

3368

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

38.1

24.0

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

21.0

23.9

M05BA07

ATC

risedronic acid; oral

3.2

23.8

310

48509

ICD-8 Finland

Bronchopneumonia, unspecified

7.0

23.8

I45.9

ICD-10 Finland

Conduction disorder, unspecified

7.3

23.8

J01.1

ICD-10 Finland

Acute frontal sinusitis

5.6

23.7

B44.8

ICD-10 Finland

Other forms of aspergillosis

243.2

23.7

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

8.7

23.7

C08DA01

ATC

verapamil; systemic

3.0

23.6

109

381

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

23.4

141

567

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.2

23.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

23.1

267

1418

RF410, ,

NOMESCO Finland

6.1

23.0

R03DX09

ATC

mepolizumab; parenteral

+∞

23.0

3028

Kela drug reimbursment

Mepolizumab

+∞

23.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

23.0

257

1348

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

5.1

22.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

22.9

471

3014

L17

ICPC

Foot/toe symptom/complaint

1.7

22.8

537

3570

SPAT1059

SPAT

Spirometry at the office

3.0

22.6

103

357

A01AB10

ATC

natamycin; local oral

3.8

22.6

195

N05CF01

ATC

zopiclone; oral

1.7

22.5

616

4260

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.4

22.3

J01DA09

ATC

[U] cefadroxil

1.8

22.0

456

2919

297, ,

Kela drug reimbursment

+∞

21.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

21.9

328

1901

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

116.5

21.6

R83

ICPC

Respiratory infection other

1.9

21.5

338

1987

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.3

21.5

130

S18

ICPC

Laceration/cut

1.6

21.4

839

6335

SPAT1260

SPAT

Consultation of another employee

1.9

21.4

344

2038

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

21.4

261

1411

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.5

21.3

227

R09

ICPC

Sinus symptom/complaint

2.4

21.2

148

638

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

21.2

111

416

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

21.2

126

504

6BA02, ,

NOMESCO Finland

34.2

21.1

ZXA05

NOMESCO Finland

Left side

1.7

20.9

484

3187

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

37.7

20.8

R03AC04

ATC

fenoterol; inhalant

37.7

20.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

20.8

238

1257

J05AH02

ATC

oseltamivir; oral

8.8

20.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

20.7

123

492

E000001, ,

ATC

1.8

20.6

339

2020

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

212.4

20.6

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.5

20.5

136

573

J18

ICD-10 Finland

Pneumonia, organism unspecified

6.8

20.4

S97

ICPC

Chronic ulcer skin

2.4

20.4

144

624

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

48.6

20.2

UJF32

NOMESCO Finland

Coloscopy

1.7

20.2

501

3358

J41.0

ICD-10 Finland

Simple chronic bronchitis

8.5

20.2

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

6.6

20.1

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.4

20.0

217

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

20.0

316

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

19.8

590

4140

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

19.8

228

1205

J34.2

ICD-10 Finland

Deviated nasal septum

2.8

19.8

362

DHB50

NOMESCO Finland

Turbinoplasty

4.1

19.6

135

N06AB04

ATC

citalopram; systemic

1.8

19.5

360

2218

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

19.5

676

4920

P01AB01

ATC

metronidazole; oral, rectal

1.6

19.5

676

4922

R23.3

ICD-10 Finland

Spontaneous ecchymoses

4.1

19.4

136

A28

ICPC

Limited function/disability NOS

1.8

19.4

382

2398

DPA30

NOMESCO Finland

Sphenotomy

15.8

19.3

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

16.9

19.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

19.2

455

3006

ZXA00

NOMESCO Finland

Right side

1.7

19.1

512

3492

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.5

19.0

104

RF420, ,

NOMESCO Finland

5.2

18.9

R03DA05

ATC

aminophylline; systemic, rectal

8.2

18.8

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.2

18.8

236

348

Kela drug reimbursment

Roflumilast

28.2

18.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

18.6

169

815

J86.9

ICD-10 Finland

Pyothorax without fistula

6.1

18.6

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

4.0

18.6

136

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

192.0

18.6

SPAT1057

SPAT

Peak expiratory flow measurement

4.4

18.5

106

R53

ICD-10 Finland

Malaise and fatigue

1.7

18.5

427

2796

R42

ICD-10 Finland

Dizziness and giddiness

1.7

18.4

436

2875

A03FA02

ATC

cisapride; oral, rectal

2.2

18.4

164

786

R01AD59

ATC

mometasone, combinations; nasal

3.4

18.3

204

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

18.3

500

3422

J01

ICD-10 Finland

Acute sinusitis

2.8

18.1

345

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

6.3

18.0

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

33.3

18.0

WX722

NOMESCO Finland

PEEP

2.7

18.0

375

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

17.9

197

1023

A01

ICPC

Pain general/multiple sites

2.1

17.7

182

921

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.6

17.7

106

425

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

17.7

641

4686

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.9

17.7

315

S51.8

ICD-10 Finland

Open wound of other parts of forearm

6.2

17.7

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.2

17.6

158

758

R75

ICPC

Sinusitis acute/chronic

2.8

17.6

327

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

37.1

17.6

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

17.6

114

475

M79.6

ICD-10 Finland

Pain in limb

1.6

17.6

710

5320

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

24.3

17.3

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

42.4

17.3

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

17.2

176

890

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

17.1

269

1573

E000007, ,

ATC

2.6

17.1

101

402

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

17.1

114

481

RF210, ,

NOMESCO Finland

3.3

17.0

193

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.0

373

2402

F2680, ,

NOMESCO Finland

50.5

17.0

GDC00

NOMESCO Finland

Lobectomy of lung

7.6

17.0

R03AC19

ATC

olodaterol

17.6

16.9

RS221, ,

NOMESCO Finland

4.9

16.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

16.8

111

467

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

16.7

165

823

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

6.8

16.6

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.9

16.6

129

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

91.0

16.6

R79

ICPC

Chronic bronchitis

16.5

16.6

L95

ICPC

Osteoporosis

2.5

16.6

104

427

R11

ICD-10 Finland

Nausea and vomiting

2.1

16.6

168

846

M05BX04

ATC

denosumab; parenteral

2.1

16.3

153

748

M25.5

ICD-10 Finland

Pain in joint

1.6

16.2

517

3654

4239

FHL

Other measure in this category

15.5

16.2

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

16.2

263

R03DX07

ATC

roflumilast; oral

30.3

16.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

16.1

372

2428

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

48.0

16.0

I50.0

ICD-10 Finland

Congestive heart failure

2.1

16.0

156

773

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

16.0

137

645

R03BB05

ATC

aclidinium bromide; inhalant

21.2

16.0

UDC00

NOMESCO Finland

Ear microscopy

2.2

15.9

146

707

J32.8

ICD-10 Finland

Other chronic sinusitis

14.6

15.8

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.6

15.8

358

L04AX01

ATC

azathioprine; systemic

2.8

15.8

289

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

15.8

222

1253

RF120, ,

NOMESCO Finland

5.1

15.8

J01MA01

ATC

ofloxacin; systemic

2.1

15.7

163

827

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

15.7

434

2959

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

15.7

524

3738

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.5

15.6

408

R4190

NOMESCO Finland

Nutritional therapy

3.0

15.5

231

R06.5

ICD-10 Finland

Mouth breathing

2.2

15.5

139

667

ZY010

NOMESCO Finland

Hospital outpatient

2.8

15.5

292

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

15.5

118

529

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

15.4

161

819

N06AA09

ATC

amitriptyline; systemic

2.0

15.4

192

1040

N02AA05

ATC

oxycodone; systemic

1.7

15.3

358

2338

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.0

15.3

170

885

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

5.1

15.3

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

16.2

15.2

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

15.2

141

685

D07AA02

ATC

hydrocortisone; topical

1.9

15.2

216

1222

Z50.1

ICD-10 Finland

Other physical therapy

2.3

15.1

113

502

J01MA11

ATC

grepafloxacin; oral

45.4

15.1

R04

ICPC

Breathing problem other

2.8

15.0

280

L03

ICPC

Low back symptom/complaint

1.6

15.0

459

3203

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.5

15.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

15.0

191

1043

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

5.2

14.9

R03

ICPC

Wheezing

5.1

14.8

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

25.3

14.7

A06AD11

ATC

lactulose; oral

1.7

14.6

293

1835

A04

ICPC

Weakness/tiredness general

1.7

14.6

272

1669

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

+∞

14.6

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

14.6

M01AH02

ATC

rofecoxib; oral

1.8

14.6

248

1483

N05BA04

ATC

oxazepam; oral

1.6

14.5

447

3119

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

14.5

176

944

GD1AA, ,

SPAT

2.1

14.5

153

781

J33.9

ICD-10 Finland

Nasal polyp, unspecified

4.8

14.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.0

14.4

219

R51.80

ICD-10 Finland

Headache

1.8

14.4

241

1433

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.5

14.4

387

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.0

14.4

225

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

14.3

133

647

C03DA01

ATC

spironolactone; oral

1.8

14.3

237

1405

N06AX21

ATC

duloxetine; oral

1.9

14.3

195

1088

J32.1

ICD-10 Finland

Chronic frontal sinusitis

11.5

14.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.7

14.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

14.2

668

5106

H66.9

ICD-10 Finland

Otitis media, unspecified

2.5

14.1

348

M02AA07

ATC

piroxicam; topical

1.5

14.1

642

4873

L14

ICPC

Leg/thigh symptom/complaint

2.0

14.1

160

839

M03BX02

ATC

tizanidine; oral

1.5

14.1

959

7890

P03

ICPC

Feeling depressed

2.2

14.0

126

605

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

13.9

197

1112

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

13.9

303

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

13.9

580

4321

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

13.9

313

2022

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

20.2

13.8

UJD02

NOMESCO Finland

Gastroscopy

2.4

13.7

427

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

13.7

204

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.5

13.6

133

N05BA01

ATC

diazepam; systemic, rectal

1.8

13.6

228

1355

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

13.6

190

1068

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

13.6

675

5205

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

75.7

13.6

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

75.7

13.6

C08DB01

ATC

diltiazem; oral

2.2

13.4

113

529

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

13.4

663

5108

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

13.3

209

1218

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

10.6

13.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.0

13.2

192

D72.1

ICD-10 Finland

Eosinophilia

13.9

13.2

J05AB11

ATC

valaciclovir; oral

1.7

13.2

254

1571

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

13.2

150

787

R01AD

ATC

Corticosteroids

4.7

13.1

G44.2

ICD-10 Finland

Tension-type headache

1.8

13.1

213

1256

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.1

13.1

183

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

16.8

13.0

N06AX11

ATC

mirtazapine; oral

1.5

13.0

553

4126

AA1AD

NOMESCO Finland

CT of head and brain

1.5

12.9

513

3770

R04.0

ICD-10 Finland

Epistaxis

2.0

12.9

150

792

-1, ,

NOMESCO Finland

1.5

12.9

487

3543

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

12.7

287

1852

R13

ICD-10 Finland

Dysphagia

2.0

12.7

135

692

R01AC02

ATC

levocabastine; nasal

3.4

12.6

130

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

12.6

430

R03CC03

ATC

terbutaline; systemic

4.8

12.6

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

70.4

12.6

A02BA04

ATC

nizatidine; systemic

2.0

12.6

152

814

R03DX10

ATC

benralizumab; systemic

+∞

12.5

49309

ICD-8 Finland

Asthma, Unspecified

+∞

12.5

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

9.4

12.5

RK250, ,

NOMESCO Finland

9.4

12.5

JN4BD

NOMESCO Finland

Extensive body CT

1.8

12.5

203

1196

J43.1

ICD-10 Finland

Panlobular emphysema

130.9

12.4

B44.9

ICD-10 Finland

Aspergillosis, unspecified

130.9

12.4

318

Kela drug reimbursment

Teriparatide

5.7

12.4

R06AX12

ATC

terfenadine; oral

2.5

12.4

333

S22.3

ICD-10 Finland

Fracture of rib

2.0

12.3

127

644

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

12.2

241

M54.5

ICD-10 Finland

Low back pain

1.5

12.1

555

4189

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

12.1

710

5618

S16

ICPC

Bruise/contusion

2.7

12.1

253

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

12.1

337

N02AC04

ATC

dextropropoxyphene; oral

2.5

12.1

331

B01AB05

ATC

enoxaparin; parenteral

1.5

12.1

564

4274

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.3

12.0

420

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.7

12.0

243

H01

ICPC

Ear pain/earache

1.8

12.0

171

968

R03BB06

ATC

glycopyrronium bromide; inhalant

13.5

11.9

ZXD20

NOMESCO Finland

Day surgery

1.7

11.9

219

1335

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

11.9

122

616

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.6

11.9

Z50.5

ICD-10 Finland

Speech therapy

4.6

11.9

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

47.0

11.9

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.1

11.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

11.8

126

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.2

11.8

N05BB01

ATC

hydroxyzine; systemic

2.2

11.8

102

483

R01

ICPC

Pain respiratory system

3.8

11.8

M48.0

ICD-10 Finland

Spinal stenosis

1.7

11.8

241

1514

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

9.0

11.8

A02BX02

ATC

sucralfate; oral

2.4

11.7

348

B01AC04

ATC

clopidogrel; oral

1.6

11.7

311

2084

R35

ICD-10 Finland

Polyuria

2.0

11.7

128

662

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

11.6

146

792

B05BB01

ATC

electrolytes; parenteral

19.1

11.6

J30.0

ICD-10 Finland

Vasomotor rhinitis

3.0

11.5

175

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.5

285

1879

3027

Kela drug reimbursment

Benralizumab

+∞

11.5

251, ,

Kela drug reimbursment

+∞

11.5

ZXD05

NOMESCO Finland

Urgent procedure

1.5

11.5

476

3517

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

120.8

11.4

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

11.4

366

XG460

NOMESCO Finland

Short time oxymetry

3.6

11.3

105

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.3

11.3

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

11.2

199

1200

UKC02

NOMESCO Finland

Cystoscopy

1.6

11.2

287

1905

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.6

11.2

101

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.8

11.1

UGC02

NOMESCO Finland

Rigid bronchoscopy

12.8

11.1

R01BA01

ATC

phenylpropanolamine; oral

2.2

11.1

461

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

11.1

121

626

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

11.2

11.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

11.0

191

1145

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.5

11.0

107

A01AC01

ATC

triamcinolone; local oral

3.3

11.0

122

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.6

10.9

D11AH05

ATC

dupilumab; topical

43.6

10.9

395

Kela drug reimbursment

Dupilumab

43.6

10.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

10.9

291

SPAT1216

SPAT

Assessment of functional ability

1.6

10.9

310

2109

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

5.4

10.9

H05AA02

ATC

teriparatide; parenteral

5.4

10.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

10.9

176

1034

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.6

10.8

250

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

10.8

288

1930

J01EA01

ATC

trimethoprim; systemic

1.5

10.8

452

3339

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

10.8

110

555

-44

ICPC

Preventive immunization/medic

1.8

10.8

159

909

N06AB10

ATC

escitalopram; oral

1.6

10.8

275

1825

A08

ICPC

Swelling

2.1

10.7

107

535

J01CF05

ATC

flucloxacillin; systemic

2.1

10.7

102

501

R03DB04

ATC

theophylline and adrenergics; systemic

28.2

10.7

D02AX

ATC

Other emollients and protectives

2.8

10.7

188

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

10.7

130

698

J02AC02

ATC

itraconazole; systemic

1.6

10.7

287

1927

R4120

NOMESCO Finland

Occupational therapy

2.0

10.7

114

585

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

10.7

409

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

60.4

10.6

R43

ICPC

Respiratory, Other diagnostic procedure

5.3

10.6

L02

ICPC

Back symptom/complaint

1.8

10.6

151

854

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.6

10.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

10.5

293

1983

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

10.5

435

3205

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

10.5

347

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

10.5

268

1778

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

10.5

452

A99

ICPC

Disease/condition unspecnature/site

1.8

10.4

170

1001

SPAT1342

SPAT

Referral to specialised care

3.9

10.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

10.4

411

2999

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

10.4

292

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.3

10.4

368

L04AA06

ATC

mycophenolic acid; systemic

3.6

10.3

J05AB01

ATC

aciclovir; systemic

1.5

10.3

358

2543

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

23.5

10.2

G04CA02

ATC

tamsulosin; oral

1.5

10.2

376

2703

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.7

10.2

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

5.3

10.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.1

232

1498

S01GX02

ATC

levocabastine; ophthalmic

2.2

10.1

412

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

10.1

158

920

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

8.5

10.0

Z00.0

ICD-10 Finland

General medical examination

1.5

10.0

312

2163

N03AE01

ATC

clonazepam; systemic

2.1

10.0

480

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

10.0

137

765

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

10.0

407

B01AA03

ATC

warfarin; systemic

1.5

9.9

356

2543

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

9.9

174

1046

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

9.9

317

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

9.9

400

2927

R2110

NOMESCO Finland

Giving the first information

2.0

9.9

101

510

B01AF02

ATC

apixaban; oral

1.6

9.8

246

1622

P01BA02

ATC

hydroxychloroquine; oral

1.8

9.8

141

799

DHA10

NOMESCO Finland

Biopsy of cavity of nose

4.9

9.8

SPAT1104

SPAT

Monitoring of emergency patient

1.9

9.8

118

632

SPAT1301

SPAT

No procedures

1.4

9.8

530

4097

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

9.7

253

1684

Q32.0

ICD-10 Finland

Congenital tracheomalacia

55.3

9.7

J04.0

ICD-10 Finland

Acute laryngitis

2.8

9.6

165

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.9

9.6

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

7.9

9.6

127

Kela drug reimbursment

Transplant complication

3.8

9.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

9.6

175

1064

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

9.6

1096

9579

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

9.6

303

L12

ICPC

Hand/finger symptom/complaint

1.6

9.6

249

1657

WX730

NOMESCO Finland

Conventional respirator

3.7

9.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

9.5

219

1414

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

15.1

9.5

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

9.5

237

1561

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

9.5

201

1272

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.7

9.5

195

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

9.5

138

786

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.5

362

2619

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

9.4

284

1953

C01AA05

ATC

digoxin; systemic

1.8

9.4

154

907

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

9.4

383

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

9.4

299

GDG10

NOMESCO Finland

Bilateral transplantation of lung

30.2

9.4

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

9.4

299

2082

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

+∞

9.4

M05BA06

ATC

ibandronic acid; systemic

2.6

9.4

208

R06.4

ICD-10 Finland

Hyperventilation

3.8

9.3

R27

ICPC

Fear of respiratory disease other

4.0

9.3

S51.0

ICD-10 Finland

Open wound of elbow

4.0

9.3

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

6.9

9.3

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

9.3

146

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

9.3

288

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

9.3

1076

9399

WX872

NOMESCO Finland

Intensive care

2.0

9.3

467

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.2

9.2

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

9.1

110

589

S01

ICPC

Pain/tenderness of skin

2.1

9.1

388

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

9.1

114

618

E66.8

ICD-10 Finland

Other obesity

2.4

9.1

278

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

5.0

9.1

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

9.1

512

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

9.1

418

3130

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

4.6

9.1

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

9.1

103

541

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.6

9.0

206

1327

S29

ICPC

Skin symptom/complaint other

1.5

9.0

314

2228

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.0

126

709

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

9.0

106

564

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

9.0

242

1623

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

9.0

309

2186

S01GX05

ATC

lodoxamide; ophthalmic

3.9

9.0

C01DA14

ATC

isosorbide mononitrate; oral

1.5

8.9

293

2051

XG420

NOMESCO Finland

Time-volume spirometry

18.7

8.9

Z94.2

ICD-10 Finland

Lung transplant status

18.7

8.9

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

8.9

345

E000002, ,

ATC

1.7

8.9

153

914

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

8.9

446

SPAT1262

SPAT

Handing over of treatment supplies

1.5

8.9

300

2112

S76

ICPC

Skin infection other

2.0

8.9

474

P01

ICPC

Feeling anxious/nervous/tense

1.9

8.9

120

667

R07.3

ICD-10 Finland

Other chest pain

1.7

8.9

175

1087

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

8.8

172

1064

M79.1

ICD-10 Finland

Myalgia

1.6

8.8

218

1432

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

8.8

468

3594

SPAT1060

SPAT

Administration of oxygen

8.6

8.8

A92

ICPC

Allergy/allergic reaction NOS

2.9

8.8

140

RD210, ,

NOMESCO Finland

3.4

8.8

L20.0

ICD-10 Finland

Besnier prurigo

2.2

8.8

361

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

8.7

288

2018

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

7.2

8.7

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.7

8.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

8.7

312

2224

344

Kela drug reimbursment

Omalizumab

50.2

8.7

AN1

Coronary angiography

1.6

8.7

204

1325

M01AB55

ATC

diclofenac, combinations; oral

1.8

8.6

126

718

RS220, ,

NOMESCO Finland

3.8

8.6

B37.08

ICD-10 Finland

Other candidal stomatitis

4.4

8.6

XF404

NOMESCO Finland

Ambulatory ECG

1.7

8.6

157

954

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

3.6

8.6

SPAT1036

SPAT

Maxillary puncture

11.6

8.6

WVA20

NOMESCO Finland

Medicine administration

2.6

8.5

182

JN4AD

NOMESCO Finland

Body CT examination

1.7

8.5

179

1129

F1246, ,

NOMESCO Finland

27.7

8.5

J67.0

ICD-10 Finland

Farmer lung

27.7

8.5

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.4

8.5

243

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

8.5

319

2296

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.2

8.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

8.5

143

R03DX05

ATC

omalizumab; parenteral

90.5

8.4

L04AA01

ATC

[U] ciclosporin

3.5

8.4

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.8

8.4

155

B80

ICPC

Iron deficiency anaemia

2.8

8.4

155

SPAT1310

SPAT

Counselling related to known health issue

1.4

8.4

510

4003

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

12.8

8.4

R49.03

ICD-10 Finland

Atrophic dysphonia

3.4

8.4

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.4

414

3136

G01AF04

ATC

miconazole; vaginal

2.1

8.4

395

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

M36.8*D80.1

ICD-10 Finland

Systemic disorders of connective tissue in hypogammaglobulinaemia

+∞

8.3

E000003, ,

ATC

2.2

8.3

322

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.1

8.3

389

ZX112

NOMESCO Finland

Subcutaneous

2.6

8.3

173

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

8.3

113

631

J01CA02

ATC

pivampicillin; oral

2.5

8.3

203

R5110, ,

SPAT

1.8

8.2

123

707

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

8.2

210

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

8.2

118

670

A02BA03

ATC

famotidine; systemic

2.2

8.2

331

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

8.2

322

2337

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

8.2

305

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.1

361

2679

N05CD07

ATC

temazepam; oral

1.6

8.1

208

1377

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

8.1

445

3428

A02

ICPC

Chills

4.6

8.1

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

8.1

192

1248

J01.4

ICD-10 Finland

Acute pansinusitis

6.8

8.1

K07

ICPC

Swollen ankles/oedema

1.9

8.0

506

SPAT1131

SPAT

Colonoscopy

2.3

8.0

281

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

8.0

176

N17

ICPC

Vertigo/dizziness

1.6

8.0

221

1488

R01AC07

ATC

nedocromil; nasal

10.1

8.0

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

6.3

8.0

A02BC04

ATC

rabeprazole; oral

1.7

8.0

138

826

R07.0

ICD-10 Finland

Pain in throat

2.0

8.0

465

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.0

118

676

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

7.9

335

A07DA03

ATC

loperamide; oral

2.3

7.9

276

H65.0

ICD-10 Finland

Acute serous otitis media

3.4

7.9

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

7.9

106

588

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

7.9

117

670

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.5

7.9

X57

ICD-10 Finland

Unspecified privation

2.8

7.9

143

50708

ICD-8 Finland

Hay fever, Alia definita

7.8

7.9

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

7.9

294

2111

L29

ICPC

Musculoskeletal sympt/complt other

1.7

7.9

142

861

L08

ICPC

Shoulder symptom/complaint

1.4

7.9

341

2519

ZX108

NOMESCO Finland

Inhalation

6.1

7.8

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

7.8

337

ZXC60

NOMESCO Finland

Application of heat

3.5

7.8

R21

ICPC

Throat symptom/complaint

1.5

7.8

241

1663

RF220, ,

NOMESCO Finland

3.3

7.8

ZX114

NOMESCO Finland

Intramuscular

3.3

7.8

R01AX03

ATC

ipratropium bromide; nasal

2.6

7.8

167

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.7

7.8

144

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

7.8

144

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

7.8

111

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

7.8

234

S21

ICPC

Skin texture symptom/complaint

1.5

7.8

228

1557

L01BA01

ATC

methotrexate; systemic

2.2

7.8

305

F34.1

ICD-10 Finland

Dysthymia

2.4

7.7

216

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

45.2

7.7

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

45.2

7.7

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.9

7.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

7.7

228

1560

315

Kela drug reimbursment

Clopidogrel

3.5

7.7

J43.8

ICD-10 Finland

Other emphysema

7.5

7.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

7.7

529

WX213

NOMESCO Finland

Lower leg blockade

4.5

7.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

7.7

217

N02BF02

ATC

pregabalin; oral

1.9

7.6

465

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

7.6

163

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.4

7.6

205

SPAT1252

SPAT

Overall medication plan or its review

1.7

7.6

125

738

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

7.6

153

955

R25

ICPC

Sputum/phlegm abnormal

18.4

7.6

R03BA07

ATC

mometasone; inhalant

8.1

7.6

S81

ICD-10 Finland

Open wound of lower leg

8.1

7.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

7.6

417

XQ820

NOMESCO Finland

Exposure to medicinal substance

11.9

7.6

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

25.1

7.6

N06AX16

ATC

venlafaxine; oral

1.6

7.6

188

1236

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.5

7.6

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.1

7.5

322

SPAT1336

SPAT

Request for examination

2.1

7.5

309

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

7.5

963

8414

J01MA06

ATC

norfloxacin; oral

1.5

7.5

215

1461

DC1AD

NOMESCO Finland

Temporalbone CT

3.7

7.5

L50.0

ICD-10 Finland

Allergic urticaria

2.6

7.5

159

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

80.4

7.4

D07AC01

ATC

betamethasone; topical

1.3

7.4

550

4439

D01BA02

ATC

terbinafine; oral

1.4

7.4

391

2989

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.0

7.4

A34

ICPC

General and Unspecified, Blood test

3.1

7.3

L16

ICPC

Ankle symptom/complaint

1.6

7.3

171

1108

L13

ICPC

Hip symptom/complaint

1.4

7.3

322

2383

0310A

ICD-9 Finland

Diseases due to other mycobacteria, Pulmonary

+∞

7.3

D80.6

ICD-10 Finland

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

+∞

7.3

T08

ICPC

Weight loss

2.8

7.3

121

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

9.4

7.3

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.4

7.3

210

K59.0

ICD-10 Finland

Constipation

1.8

7.2

539

D06BB03

ATC

aciclovir; topical

2.0

7.2

396

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.4

7.2

204

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

7.2

314

A11

ICPC

Chest pain NOS

1.7

7.2

142

881

J01DA39

ATC

[U] ceftibuten

15.8

7.2

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

7.2

301

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

7.2

103

584

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

7.2

369

R07

ICPC

Sneezing/nasal congestion

2.0

7.2

418

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

7.2

804

6876

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

7.2

519

SPAT1229

SPAT

Assessment of need for aid

1.7

7.2

145

907

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

30.1

7.1

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

30.1

7.1

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

7.1

224

S01GX04

ATC

nedocromil; ophthalmic

3.1

7.1

50304

ICD-8 Finland

Chronic sinusitis, Ethmoidalis

20.1

7.1

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

7.1

250

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.3

7.1

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

8.0

7.1

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.1

820

7039

L04AD02

ATC

tacrolimus; systemic

4.1

7.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

7.1

225

M79.7

ICD-10 Finland

Fibromyalgia

2.3

7.1

225

TPH04, ,

SPAT

5.6

7.1

SPAT1211

SPAT

Application of soft bandage

1.6

7.1

146

918

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.0

202

1372

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

7.0

175

1151

R4130

NOMESCO Finland

Speech therapy

2.5

7.0

176

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

7.0

258

L05

ICPC

Flank/axilla symptom/complaint

1.8

7.0

103

589

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

7.0

C10AC01

ATC

colestyramine; oral

2.4

7.0

195

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

7.0

102

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

7.0

147

SCA02

NOMESCO Finland

Preventive oral health care

1.7

7.0

129

788

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

7.0

259

R55

ICD-10 Finland

Syncope and collapse

1.5

6.9

191

1286

ZY000

NOMESCO Finland

Hospital inpatient

3.7

6.9

R05DB20

ATC

other cough suppressants - combinations

1.9

6.9

460

L03

ICD-10 Finland

Cellulitis

4.0

6.9

GX1D5

NOMESCO Finland

Flow volume spirometry

13.8

6.9

U02

ICPC

Urinary frequency/urgency

1.5

6.9

242

1715

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

6.9

485

3876

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

6.8

390

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

6.8

154

989

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

6.8

382

2943

GX1K5

NOMESCO Finland

Diffusion capacity

8.3

6.8

M05BX03

ATC

strontium ranelate; oral

4.1

6.8

J01X

ATC

OTHER ANTIBACTERIALS

6.7

6.8

Z51.6

ICD-10 Finland

Desensitization to allergens

9.3

6.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.8

670

5618

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

5.7

6.8

D84.1

ICD-10 Finland

Defects in the complement system

40.2

6.8

L01

ICPC

Neck symptom/complaint

1.5

6.8

222

1552

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

16.8

6.7

SPAT1097

SPAT

Recording of ECG

1.5

6.7

253

1816

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

6.7

100

574

D01

ICPC

Abdominal pain/cramps general

1.6

6.7

168

1106

U71

ICPC

Cystitis/urinary infection other

1.7

6.7

114

680

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.1

6.7

283

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

6.7

372

M81.5

ICD-10 Finland

Idiopathic osteoporosis

3.4

6.7

KMAK, ,

NOMESCO Finland

1.3

6.7

718

6086

A91

ICPC

Abnormal result investigation NOS

1.9

6.7

458

F01

ICPC

Eye pain

2.4

6.7

187

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.7

6.6

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

6.6

317

2377

G25.0

ICD-10 Finland

Essential tremor

2.3

6.6

206

D07AB08

ATC

desonide; topical

1.6

6.6

155

1005

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

6.6

543

4433

H26.3

ICD-10 Finland

Drug-induced cataract

5.9

6.6

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.3

6.6

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.4

6.6

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.5

548

4485

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

6.5

564

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.5

241

1723

N02BF01

ATC

gabapentin; oral

1.7

6.5

127

786

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

6.5

633

5288

A29

ICPC

General symptom/complaint other

1.5

6.5

205

1420

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.0

6.5

-1, ,

ICPC

2.0

6.5

335

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

6.5

165

1092

A03DA02

ATC

pitofenone and analgesics; systemic

2.5

6.5

165

J01CF02

ATC

cloxacillin; systemic

2.5

6.5

153

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.9

6.4

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

6.4

261

4738X

ICD-9 Finland

Chronic sinusitis, Other chronic sinusitis

70.1

6.4

D84.18

ICD-10 Finland

Other specified defect in the complement system

70.1

6.4

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

70.1

6.4

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

6.4

184

OAB50, ,

SPAT

1.8

6.4

486

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

6.4

171

1143

N06AX12

ATC

bupropion; oral

2.0

6.4

357

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

6.4

295

5AH02, ,

NOMESCO Finland

14.4

6.4

R5599

NOMESCO Finland

Other rehabilitation service

2.3

6.4

216

N03AX09

ATC

lamotrigine; oral

2.2

6.4

242

R33

ICD-10 Finland

Retention of urine

1.6

6.4

130

815

R52.9

ICD-10 Finland

Pain, unspecified

1.6

6.3

145

935

Z2445

NOMESCO Finland

Psychologist

2.3

6.3

204

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.3

579

4793

N39.3

ICD-10 Finland

Stress incontinence

1.7

6.3

126

785

K22.2

ICD-10 Finland

Oesophageal obstruction

3.6

6.3

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.6

6.3

SBA00

NOMESCO Finland

Microbiological examinations

2.3

6.3

198

G01AF05

ATC

econazole; vaginal

1.7

6.3

106

631

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.5

6.3

1DC02, ,

NOMESCO Finland

11.1

6.3

I20.00

ICD-10 Finland

Unstable angina

2.1

6.3

257

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.0

6.3

N01

ICPC

Headache

1.6

6.3

135

858

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.3

6.3

205

F29

ICPC

Eye symptom/complaint other

1.6

6.3

144

930

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

18.1

6.3

J98.2

ICD-10 Finland

Interstitial emphysema

18.1

6.3

J17.2*B44.1

ICD-10 Finland

Pneumonia in other aspergillosis

+∞

6.3

D84.19

ICD-10 Finland

Unspecified defect in the complement system

+∞

6.3

RF531, ,

NOMESCO Finland

+∞

6.3

J06BA02

ATC

immunoglobulins, normal human, for intravascular adm.; systemic

+∞

6.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

6.2

110

664

J20.1

ICD-10 Finland

Acute bronchitis due to Haemophilus influenzae

26.8

6.2

A31.89

ICD-10 Finland

Other mycobacterial infections

26.8

6.2

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

6.2

425

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

6.2

225

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.2

211

1484

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

6.2

326

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

6.2

150

980

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

6.2

162

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

6.2

206

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

6.2

581

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

5.0

6.2

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

4.0

6.2

R44

ICPC

Respiratory, Preventive immunization/medic

2.6

6.1

127

XKC03

NOMESCO Finland

Water cystometry

2.1

6.1

266

C02DE01, ,

ATC

3.3

6.1

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

6.1

427

B07.9

ICD-10 Finland

Verruca simplex

2.2

6.1

220

J43.2

ICD-10 Finland

Centrilobular emphysema

7.7

6.1

-50

ICPC

Medication/prescr/renewal

1.9

6.1

356

Z31.5

ICD-10 Finland

Genetic counselling

2.0

6.1

328

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.7

6.1

116

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.0

6.1

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

6.1

329

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.1

238

1722

SFA20

NOMESCO Finland

Two-surface restoration

1.3

6.0

821

7145

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.0

6.0

309

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.0

6.0

323

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

6.0

344

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

353

129

34.05

307.65

6.7

3.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

516

484

14.72

307.65

5.0

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

648

536

18.64

307.65

2.3

1.1

277.47

180.29

u/ml

1.70

625

473

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

339

150.02

307.65

2.0

1.2

3.01

0.51

u/ml

3.98

261

(3023419) Bacteria identified in Sputum by Culture

719

176

68.78

307.65

5.4

2.1

—

(4062490) Immunoglobulin typing, IgG

205

108

21.38

266.12

1.5

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

202

105

21.63

263.73

1.5

1.3

6.63

7.29

g/l

0.61

147

(3024139) IgG subclass 3 [Mass/volume] in Serum

202

105

21.63

263.73

1.5

1.3

0.38

0.45

g/l

0.76

148

(3028192) IgG subclass 2 [Mass/volume] in Serum

202

105

21.63

263.73

1.5

1.3

2.81

2.73

g/l

0.14

145

(4200892) Spirometry reversibility

466

853

7.09

257.10

1.9

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

163

32.00

248.38

7.2

3.6

—

(3042631) Mycobacterium sp identified in Specimen

230

190

13.79

235.72

6.5

2.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

492

1048

6.15

230.80

3.9

2.7

10.19

10.79

g/l

1.87

470

945

(3000494) Fungus identified in Specimen by Culture

616

1641

5.26

223.72

2.8

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

218

182

13.55

221.71

1.5

0.67

0.79

g/l

0.54

160

139

(3013115) Eosinophils [#/volume] in Blood

1372

7232

5.20

193.79

10.8

5.8

0.22

0.19

e9/l

11.22

1281

6262

(3001604) Monocytes [#/volume] in Blood

1346

6994

5.04

193.74

10.2

5.6

0.66

0.59

e9/l

16.92

1252

5970

(3006315) Basophils [#/volume] in Blood

1347

7006

5.05

193.55

10.2

5.6

0.05

0.04

e9/l

9.19

1253

5989

(40760892) CBC W Ordered Manual Differential panel - Blood

1296

6561

4.79

192.83

10.7

6.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

398

835

5.88

187.07

2.1

1.8

1.05

1.53

g/l

3.79

375

751

(3019198) Lymphocytes [#/volume] in Blood

1352

7156

4.95

186.90

10.3

5.7

1.94

1.92

e9/l

0.07

1272

6264

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

242

314

8.79

179.01

2.2

1.4

—

(3022096) Basophils/100 leukocytes in Blood

1243

6426

4.25

171.22

10.7

5.9

0.68

0.67

0.15

1218

5940

(3019069) Monocytes/100 leukocytes in Blood

1259

6630

4.23

167.23

11.2

6.2

8.75

8.84

0.53

1234

6147

(3006504) Eosinophils/100 leukocytes in Blood

1255

6605

4.21

166.58

10.9

5.9

3.05

2.78

2.69

1231

6110

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

707

2540

4.00

166.32

2.9

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

1257

6641

4.19

165.45

10.6

5.8

60.01

57.63

10.07

1233

6160

(3002030) Lymphocytes/100 leukocytes in Blood

1264

6773

4.14

161.22

11.0

6.0

24.79

27.21

13.52

1240

6291

(3000492) Spirometry study

404

995

4.98

156.20

2.3

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

553

1759

4.14

152.93

2.7

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

174

183

10.45

150.71

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1403

8297

4.53

149.97

12.5

9.1

4.89

4.08

e9/l

23.63

1315

7200

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

543

1749

4.06

146.86

2.8

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

31.95

139.61

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

231

8.63

134.85

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

183

9.33

125.57

1.7

1.5

—

(3023368) Bacteria identified in Blood by Culture

888

4264

3.20

123.94

6.6

4.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

289

7.30

122.57

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

289

7.30

122.57

1.7

1.3

—

(3042936) Bacteria identified in Isolate by Culture

567

2105

3.51

121.09

2.6

2.0

—

(3011412) CD3 cells [#/volume] in Blood

123

115

11.43

115.18

1.6

2.1

1.41

1.05

e9/l

3.19

101

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

14.22

114.24

1.5

2.2

623.00

449.03

e6/l

1.94

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

103

14.15

110.78

1.6

2.2

0.28

0.18

e9/l

3.53

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

152

209

7.87

105.92

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

455

1605

3.48

103.47

2.7

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

182

335

5.95

95.90

2.1

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

185

347

5.85

95.56

2.1

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

136

185

7.89

95.51

1.6

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

588

2523

3.01

94.98

1.9

1.4

2.58

2.55

g/l

0.09

429

1436

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

107

113

10.02

91.81

1.9

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

10.74

85.07

1.6

2.0

72.69

71.33

0.22

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

11.24

85.02

1.6

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

10.74

84.17

1.6

2.0

14.29

15.49

0.36

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

17.06

82.61

1.3

2.2

29.77

26.20

0.72

(3006245) CD3-CD19+ cells/100 cells in Blood

16.29

80.68

1.3

2.2

11.12

13.08

0.24

(3024891) Influenza virus A+B Ag [Presence] in Specimen

158

305

5.60

78.83

1.4

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

255

6.02

77.57

2.2

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1475

10901

3.28

74.32

7.9

4.1

17.77

13.58

mm/h

16.80

1427

9951

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

131

232

6.02

71.49

2.1

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

131

232

6.02

71.49

2.1

1.6

—

(3021589) Normoblasts [#/volume] in Blood

1002

6261

2.41

69.11

14.8

9.8

0.00

e9/l

1.77

862

5091

(3027801) Oxygen [Partial pressure] in Arterial blood

413

1714

2.85

68.06

7.6

7.1

10.63

12.40

kpa

12.17

388

1634

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

413

1715

2.84

67.97

7.7

7.1

5.25

5.04

kpa

3.02

391

1632

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

109

170

6.77

67.39

1.1

1.43

1.57

g/l

2.13

103

155

(3037692) Legionella sp identified in Specimen by Organism specific culture

13.64

65.86

1.6

—

(3003396) Base excess in Arterial blood by calculation

405

1718

2.77

63.57

7.8

7.1

1.99

1.03

mmol/l

5.22

337

1336

(3000060) B lymphocytes [#/volume] in Blood

17.26

62.75

1.3

2.0

159.17

196.67

e6/l

—

(40758558) Short blood count panel - Blood

668

3626

2.36

61.86

8.8

6.8

—

(3019060) Gas panel - Arterial blood

275

979

3.15

59.06

4.8

5.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

177

473

4.05

58.99

1.8

1.5

621.82

156.00

titre

0.84

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

573

2977

2.38

57.96

2.1

1.7

1.24

1.34

mg/l

0.24

448

2319

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1139

7896

2.27

56.56

7.6

6.3

10.10

11.85

umol/l

7.95

1105

7465

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1138

7899

2.27

56.15

8.4

6.6

1.22

mmol/l

0.37

980

6630

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

267

972

3.06

54.96

2.5

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

105

196

5.64

54.06

2.0

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

283

1077

2.94

53.77

5.2

3.9

0.57

0.61

0.10

377

(21494815) CD4 cells/100 lymphocytes in Specimen

100

7.79

53.31

1.7

1.9

42.79

36.97

1.59

100

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

225

757

3.26

52.85

8.5

9.1

25.37

24.26

mmol/l

5.59

214

734

(3017181) Myelocytes/100 leukocytes in Blood

299

1183

2.84

52.82

5.5

4.1

0.73

0.89

0.54

439

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

791

4846

2.16

52.30

3.9

3.0

1395.04

1591.45

ng/l

0.66

691

4183

(3025159) Blasts/100 leukocytes in Blood

276

1053

2.93

52.11

5.6

4.2

0.03

0.09

0.79

312

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

9.81

50.58

3.1

2.2

601.47

1728.00

u/ml

1.85

(3016502) Oxygen saturation in Arterial blood

351

1540

2.60

50.44

8.0

7.5

94.47

95.60

2.34

337

1480

(3021440) Promyelocytes/100 leukocytes in Blood

285

1125

2.83

50.42

5.5

4.1

0.03

0.11

2.17

378

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1044

7200

2.12

49.58

8.0

5.8

1.21

mmol/l

0.71

972

6485

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1461

11596

2.60

48.34

11.2

7.6

78.85

79.77

u/l

0.33

1419

10806

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

91.11

48.09

1.6

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

157

5.85

47.48

2.2

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1049

7333

2.08

46.94

3.6

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

348

1587

2.49

45.72

1.5

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

277

1132

2.72

45.58

1.9

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

153

5.79

45.43

2.0

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

153

5.79

45.43

2.0

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

7.74

44.74

1.1

1.0

0.87

1.05

u/ml

0.09

(3003888) Timothy IgE Ab [Units/volume] in Serum

7.11

43.41

1.1

1.0

2.00

6.49

u/ml

1.09

(3018418) pH of Serum or Plasma

744

4692

2.02

43.16

4.7

4.0

7.40

0.32

140

899

(3037522) Nuclear Ab [Titer] in Serum

367

1762

2.37

42.76

1.3

456.23

584.06

titre

0.64

414

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

113

6.41

41.75

1.1

0.65

1.02

u/ml

0.35

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

5.94

41.34

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

5.94

41.34

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

5.94

41.34

1.9

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

110

273

4.23

40.27

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

6.73

38.86

1.1

0.53

2.06

u/ml

0.57

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

153

5.29

37.97

2.1

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

146

5.40

37.86

2.2

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

955

6784

1.90

37.04

5.2

4.7

33.69

35.06

g/l

10.79

890

6302

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

305

1431

2.37

37.01

3.5

2.9

214.56

209.32

ng/l

0.06

276

1304

(3014133) Dog dander IgE Ab [Units/volume] in Serum

7.63

36.60

1.1

1.0

4.06

1.41

u/ml

0.48

(3036481) Cortisol [Moles/volume] in Serum or Plasma

278

1260

2.43

36.41

2.6

2.1

292.59

387.90

nmol/l

12.85

261

1138

(3022948) Iron [Moles/volume] in Serum or Plasma

438

2403

2.10

36.07

2.5

10.53

12.52

umol/l

8.42

414

2225

(3018851) Theophylline [Moles/volume] in Serum or Plasma

81.93

35.94

1.4

1.8

46.10

39.00

umol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

7.97

35.85

1.1

1.0

1.93

2.77

u/ml

0.19

(3000991) Gas panel - Venous blood

272

1229

2.44

35.83

8.4

7.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

633

3981

1.93

35.22

2.7

2.2

3.12

3.03

mg/l

0.39

569

3351

(3004789) Transferrin [Mass/volume] in Serum or Plasma

406

2205

2.10

34.12

2.5

2.29

2.27

g/l

0.29

383

2027

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.47

33.89

1.9

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

510

3014

1.98

33.86

5.7

3.8

216.59

318.35

ng/l

0.95

418

2503

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

123

373

3.47

33.77

2.3

1.9

10.62

13.04

mg/l

1.93

114

337

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

279

3.86

33.42

1.2

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

439

2475

2.03

33.22

4.8

3.2

0.82

mmol/l

0.02

404

2302

(36304419) Bacteria [Presence] in Urine

638

4091

1.88

32.95

4.3

3.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1262

10007

1.94

32.91

6.5

4.9

70.71

2106.91

e6/l

2.50

152

(3014111) Lactate [Moles/volume] in Serum or Plasma

277

1313

2.32

32.55

7.7

6.4

1.31

1.40

mmol/l

0.84

264

1278

(3052851) Hemolysis interference index of Serum or Plasma

136

455

3.16

31.85

3.9

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

839

5902

1.81

31.77

3.5

2.7

144.70

143.10

ug/l

0.02

785

5339

(3013826) Glucose [Moles/volume] in Serum or Plasma

1144

8840

1.85

31.68

6.8

4.6

6.49

6.79

mmol/l

6.73

1096

8303

(3030467) Casts [#/volume] in Urine by Automated count

650

4235

1.85

31.62

4.4

3.2

0.40

0.50

e6/l

0.63

510

3261

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

196

803

2.62

31.58

10.6

10.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

382

2081

2.07

31.57

2.6

2.5

18.09

22.44

9.50

338

1767

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

7.55

31.47

1.1

1.0

0.12

0.77

u/ml

0.69

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

155

564

2.92

31.34

2.1

1.9

36.47

39.45

u/l

1.17

135

484

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

10.18

30.99

1.9

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

997

7419

1.80

30.94

17.3

17.2

1.31

1.33

inr

0.25

271

2090

(3002173) Hemoglobin [Mass/volume] in Arterial blood

291

1442

2.22

30.63

8.5

7.7

121.96

119.23

g/l

1.46

281

1400

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.60

30.34

2.0

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

590

3768

1.85

30.32

5.5

3.9

88.90

87.49

0.67

573

3672

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

4.77

29.58

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

204

884

2.48

29.16

1.9

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

228

3.92

28.75

1.7

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

683

4621

1.79

28.62

4.5

3.3

77.50

84.67

e6/l

0.09

534

3579

(3021447) Carbon dioxide [Partial pressure] in Venous blood

283

1430

2.17

28.22

3.9

3.5

6.06

5.77

kpa

3.65

270

1390

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

211

945

2.40

28.02

6.2

3.6

5.16

5.13

kpa

0.26

206

896

(3009343) pH of Capillary blood

209

934

2.41

27.89

6.1

3.6

7.43

7.41

2.45

111

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.25

27.61

2.0

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

401

2320

1.95

27.53

1.3

41.09

37.09

iu/ml

0.15

135

747

(3047007) Chlamydophila sp Ab [Presence] in Serum

141

4.67

27.22

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

279

1422

2.15

27.14

3.9

3.5

2.77

1.92

mmol/l

2.92

244

1172

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

822

5948

1.72

26.59

5.3

3.8

36.35

128.21

ng/l

0.69

628

4413

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.01

26.58

2.1

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.01

26.58

2.1

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

200

901

2.38

26.15

6.2

3.6

2.07

1.81

mmol/l

0.48

159

670

(3037467) Urinalysis macro (dipstick) panel - Urine

1254

10235

1.80

26.03

6.0

4.6

—

(3018095) Leukocytes [#/volume] in Urine

753

5352

1.72

25.75

5.3

3.8

58.83

113.65

e6/l

2.13

562

3834

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

5.39

25.68

1.3

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

650

4454

1.73

25.26

3.7

3.2

28.83

35.20

u/l

4.65

616

4215

(3000850) Epithelial cells [#/volume] in Urine

509

3269

1.79

24.71

3.4

2.6

5.55

5.78

e6/l

0.13

466

2925

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

845

6264

1.68

24.18

2.9

2.2

83.39

79.83

nmol/l

2.98

784

5477

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

119

4.74

23.91

2.0

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

117

429

2.85

23.25

2.1

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1593

14249

2.35

23.13

35.8

15.1

25.48

25.35

mg/l

0.06

1501

11338

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

54.79

23.09

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

6.21

22.88

2.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

6.21

22.88

2.2

1.7

—

(3022313) Gas panel - Capillary blood

159

686

2.45

22.80

6.9

3.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

372

2223

1.86

22.63

1.3

1.2

19.49

15.02

u/ml

0.37

130

793

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

6.11

22.53

2.3

1.7

—

(3026782) Osmolality of Urine

486

3158

1.75

22.27

3.6

2.9

508.68

534.32

mosm/kgh2o

2.34

424

2711

(3018677) aPTT in Platelet poor plasma by Coagulation assay

382

2322

1.83

21.92

2.5

2.0

30.02

29.85

0.17

371

2237

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

397

2450

1.80

21.63

3.8

2.9

2.77

2.66

e6/l

0.08

211

1363

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

415

2605

1.78

21.31

3.7

2.8

0.88

1.24

e6/l

2.05

229

1509

(40768797) Stomach Pathology biopsy report

343

2056

1.83

20.45

1.3

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

296

3.08

20.39

4.0

3.6

57.84

58.44

0.15

296

(3020630) Protein [Mass/volume] in Serum or Plasma

256

1396

1.98

20.38

2.6

2.9

65.37

66.20

g/l

0.93

231

1250

(3008152) Bicarbonate [Moles/volume] in Arterial blood

196

971

2.15

20.24

8.0

6.9

25.50

24.31

mmol/l

3.92

187

919

(3030905) Polymorphonuclear cells [#/volume] in Blood

283

3.11

20.04

3.2

3.3

4.87

4.22

e9/l

1.41

283

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

313

1839

1.86

19.85

3.9

4.1

235.27

252.86

u/l

1.34

297

1725

(3027945) Reticulocytes/100 erythrocytes in Blood

317

1878

1.84

19.56

2.6

1.77

0.01

270

1656

(3014007) Fractional oxyhemoglobin in Arterial blood

191

950

2.13

19.50

9.9

8.4

92.42

93.99

1.74

191

944

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

191

958

2.12

19.07

9.9

8.2

1.32

1.30

0.08

191

949

(3026008) Bacteria identified in Urine by Culture

702

5201

1.59

18.53

3.8

3.3

—

(3002385) Erythrocyte distribution width [Ratio]

1386

12061

1.73

18.40

34.9

18.3

15.53

15.29

0.79

1378

11821

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

145

662

2.30

18.25

3.3

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

643

4684

1.59

18.14

2.7

2.5

56.44

76.89

u/l

0.60

603

4276

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.75

18.03

1.8

2.7

40.78

39.91

0.09

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

186

950

2.07

17.67

10.1

8.4

0.61

0.68

1.64

186

942

(3024354) Oxygen [Partial pressure] in Venous blood

218

1180

1.97

17.61

3.6

2.8

4.61

4.53

kpa

0.20

205

1145

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

259

1494

1.86

17.25

2.7

2.1

0.21

g/l

0.18

246

1395

(3028433) Virus identified in Specimen by Culture

5.97

17.00

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

853

6698

1.54

16.85

2.3

2.1

93.55

94.44

pmol/l

0.21

453

3338

(3026493) Urate [Moles/volume] in Serum or Plasma

541

3839

1.59

16.78

3.5

2.8

7557.70

7670.53

umol/l

0.01

465

3288

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

122

542

2.34

16.35

3.5

2.8

0.31

0.37

u/ml

1.14

329

(3021901) Oxygen saturation in Capillary blood

262

2.95

16.30

2.6

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

497

2.38

15.94

1.1

1.2

0.35

0.45

u/ml

0.15

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

165

3.41

15.39

1.1

1.0

—

13.94

—

(3021960) Folate [Moles/volume] in Serum or Plasma

541

3916

1.55

15.07

1.7

1.6

20.17

20.75

nmol/l

0.40

491

3267

(3015736) pH of Urine

729

5637

1.50

14.86

4.2

3.7

5.98

5.81

0.34

278

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.56

14.79

1.8

2.5

1923.44

49484.78

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

109

3.92

14.53

1.1

386.00

87.14

titre

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

327

2.62

14.39

2.0

2.2

125.90

127.90

g/l

0.23

242

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

607

2.18

14.30

2.9

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

705

5456

1.49

14.09

3.1

3.4

2.35

2.36

mmol/l

1.61

620

4731

(3004588) Protein electrophoresis panel - Serum or Plasma

205

1169

1.85

14.04

2.5

2.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

268

2.76

13.96

12.1

5.5

236.53

549.73

iu/ml

1.11

(3003434) Protein [Mass/volume] in Pleural fluid

236

2.87

13.78

1.5

1.4

33.54

31.71

g/l

0.56

214

(3047181) Lactate [Moles/volume] in Blood

105

471

2.31

13.77

7.4

7.0

1.21

1.30

mmol/l

0.56

414

(3035350) Ketones [Presence] in Urine by Test strip

877

7115

1.47

13.65

4.7

4.0

0.00

estimate

0.75

203

1434

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.98

13.59

1.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

876

7117

1.46

13.47

6.3

5.3

0.00

estimate

-0.00

194

1324

(3023520) Reticulocytes [#/volume] in Blood

235

1417

1.76

13.36

2.7

2.6

70.81

68.13

e9/l

0.57

158

1077

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

411

2865

1.57

13.26

1.4

1.2

0.89

1.44

u/ml

1.61

101

710

(3009261) Glucose [Presence] in Urine by Test strip

883

7203

1.46

13.18

4.8

4.0

0.00

0.01

estimate

1.08

190

1294

(3020779) Urea [Moles/volume] in Serum or Plasma

226

1353

1.77

13.16

8.6

6.8

9.84

10.46

mmol/l

0.75

216

1284

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

625

4770

1.48

13.15

2.6

2.1

173.33

209.84

u/l

0.35

579

4446

(3023199) Leukocytes [#/volume] in Pleural fluid

221

2.87

13.04

1.4

2458.55

1651.57

e6/l

0.60

162

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

227

1375

1.75

12.67

2.4

2.2

28.30

38.25

u/l

3.92

191

1183

(3028308) Erythrocytes [#/volume] in Pleural fluid

203

2.92

12.61

1.4

1.3

69474.23

86658.96

e6/l

0.12

121

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

106

498

2.20

12.46

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

411

2.31

12.20

1.5

31.33

0.13

iu/ml

0.48

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

121

605

2.07

12.13

8.6

4.0

25.21

24.80

mmol/l

0.85

112

556

(3048689) Calprotectin [Mass/mass] in Stool

241

1505

1.70

12.03

1.9

2.1

334.81

132.62

ug/g

1.23

184

1168

(3026389) Candida sp identified in Specimen by Organism specific culture

182

2.97

11.93

1.7

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

4.45

11.92

1.1

1.0

12.18

14.49

iu/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

104

494

2.18

11.91

2.6

2.7

0.01

g/l

0.03

447

(3045788) Cell count panel - Pleural fluid

178

2.98

11.78

1.4

1.3

—

(3044889) 12 lead EKG panel

1195

10439

1.46

11.69

5.4

4.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

629

2.03

11.61

2.5

2.8

3.15

3.01

g/l

0.88

115

553

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

113

561

2.08

11.55

2.5

3.8

45.18

63.25

mg/l

0.57

467

(3003458) Phosphate [Moles/volume] in Serum or Plasma

308

2067

1.60

11.54

6.7

5.2

1.06

1.03

mmol/l

1.14

284

1890

(3011397) Hemoglobin [Presence] in Urine by Test strip

464

3408

1.49

11.52

4.7

3.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

416

2.25

11.45

2.4

3.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

675

1.98

11.42

2.4

2.7

7.80

7.40

g/l

1.77

121

598

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

675

1.98

11.42

2.4

2.7

3.70

3.59

g/l

0.46

121

598

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

675

1.98

11.42

2.4

2.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.42

11.36

1.6

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1027

8754

1.42

11.27

4.1

3.1

50.15

51.58

u/l

0.19

951

8015

(21494814) CD8 cells/100 lymphocytes in Specimen

4.95

11.22

2.2

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

112

562

2.06

11.14

2.6

3.7

94.48

68.79

mg/l

0.26

466

(1616796) Gas panel - Central venous blood

326

2.39

11.07

5.2

4.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

124

649

1.98

10.97

2.6

2.0

1.20

2.44

ug/l

0.89

114

566

(3037756) Immunofixation for Serum or Plasma

386

2.26

10.87

1.4

1.7

—

(3012441) Differential panel - Pleural fluid

181

2.87

10.85

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

261

1707

1.62

10.84

1.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

109

547

2.06

10.84

2.6

3.7

5.47

1.75

ratio

0.58

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

112

571

2.03

10.67

2.6

2.8

0.93

1.33

g/l

0.64

101

487

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

428

3135

1.48

10.65

2.8

3.1

2.48

2.46

mmol/l

3.10

362

2779

(3024928) Oxygen saturation in Venous blood

308

2.40

10.56

2.7

3.0

—

(40768804) Tissue Pathology biopsy report

734

5966

1.40

10.25

2.4

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

637

1.95

10.20

2.4

2.8

9.74

10.35

g/l

0.80

110

556

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

465

2.10

10.10

2.6

2.8

0.00

g/l

-0.00

425

(3051611) Lipemic interference index of Serum or Plasma

172

2.84

10.06

3.5

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

119

636

1.93

9.92

6.1

5.7

1.73

1.57

1.31

111

595

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

120

3.21

9.89

1.2

14.88

12.35

u/l

0.48

113

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

470

2.08

9.83

2.6

2.8

0.01

0.00

g/l

0.49

426

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

250

1666

1.58

9.55

2.5

2.7

7.65

9.28

umol/l

0.56

216

1447

(3018572) Chloride [Moles/volume] in Blood

338

2.24

9.37

8.1

8.2

103.94

105.29

mmol/l

1.11

301

(3039000) Anion gap in Blood

338

2.24

9.37

8.1

8.2

11.11

11.14

mmol/l

0.03

301

(3003181) Sodium [Moles/volume] in Urine

306

2.31

9.36

1.5

1.2

58.29

61.58

mmol/l

0.26

245

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

103

535

1.98

9.34

2.5

2.6

36.52

37.24

g/l

0.58

458

(40757373) Influenza virus identified in Isolate

6.95

9.32

1.8

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.04

9.10

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1233

11039

1.40

9.00

4.6

4.1

15.06

14.97

pmol/l

0.63

1132

9863

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

126

711

1.83

8.91

3.2

2.5

1.23

1.12

0.54

126

706

(3007930) Methemoglobin/Hemoglobin.total in Blood

115

632

1.88

8.84

6.3

5.7

0.91

0.90

0.09

107

593

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.15

8.72

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

325

2.20

8.55

1.8

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

2.54

8.52

6.3

2.9

880.00

1097.45

u/ml

—

(3051651) Icteric interference index of Serum or Plasma

3.27

8.36

3.5

3.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

215

1427

1.58

8.32

3.2

2.4

6.36

7.14

ug/l

0.33

177

1240

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

370

2.10

8.24

3.2

2.2

187.10

194.69

0.31

355

(3035880) pH of Pleural fluid

103

3.15

8.12

1.2

1.3

—

(44813793) Dust mix specific IgE antibody measurement

3.79

8.08

1.0

1.1

—

(3036489) Thrombin time

502

1.92

7.90

2.8

1.9

22.86

21.58

0.45

452

(3019550) Sodium [Moles/volume] in Serum or Plasma

1591

15061

1.64

7.87

34.7

18.0

139.11

139.66

mmol/l

13.25

1572

14665

(40768806) Pleura Pathology biopsy report

185

2.53

7.77

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

262

2.26

7.60

4.4

4.0

1.27

1.49

0.15

238

(3017732) Neutrophils [#/volume] in Blood

154

966

1.65

7.51

3.8

3.2

6.49

5.56

e9/l

0.26

134

741

(40761511) CBC panel - Blood by Automated count

1556

14685

1.55

7.42

26.2

14.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1591

15093

1.61

7.40

35.0

18.2

3.96

3.98

mmol/l

2.62

1571

14677

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.39

7.32

2.9

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

196

1315

1.55

7.23

3.9

3.5

85.03

91.90

ng/l

0.61

172

1119

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

7.95

7.10

1.2

1.3

—

(3012501) Base excess in Blood by calculation

344

2.05

7.07

6.4

4.6

2.46

2.77

mmol/l

0.55

232

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

558

1.82

7.07

3.6

2.1

416.97

850.34

ug/l

0.59

524

(3019309) Folate [Moles/volume] in Red Blood Cells

415

3226

1.38

7.05

1.9

1.8

1198.15

1165.57

nmol/l

0.25

311

2389

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.39

6.96

2.4

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

128

782

1.69

6.91

1.4

1.7

1.79

1.54

g/l

2.31

105

674

(3022145) Colonoscopy Study observation

228

1598

1.49

6.85

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

3.47

6.57

1.2

1.0

—

(3010421) pH of Blood

405

1.92

6.48

6.1

4.3

7.43

7.42

2.45

363

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

257

2.14

6.28

1.1

1.2

9.12

50.52

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

174

2.39

6.24

1.2

1.38

3.46

u/ml

0.72

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

233

1670

1.46

6.24

4.4

3.4

—

(3017569) Oxygen content in Arterial blood

3.18

6.02

1.4

2.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.48

6.01

34.8

23.1

133.54

132.48

ug/l

0.02

(40767503) Oxygen content in Capillary blood by calculation

315

1.97

5.73

3.0

2.4

16.09

15.92

0.11

148

(36660697) Celiac disease serology panel - Serum

153

1026

1.54

5.67

1.2

—

(3011648) Oxygen content in Venous blood

115

2.64

5.65

2.3

2.9

11.76

11.01

0.32

115

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

248

2.09

5.64

1.4

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1588

15210

1.49

5.35

34.1

18.3

77.85

78.86

umol/l

0.48

1588

15205

(3003327) Ova and parasites identified in Stool by Light microscopy

375

1.85

5.28

1.7

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1414

13297

1.33

5.20

5.7

4.9

1.86

2.08

mu/l

1.51

1316

11948

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

1.87

5.19

1.1

1.2

12.13

7.89

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

341

1.88

5.18

1.1

1.2

1.80

3.80

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

334

1.89

5.18

1.6

1.4

—

(3020891) Body temperature

606

1.65

5.12

5.2

4.2

—

(3029937) Albumin [Presence] in Urine by Test strip

469

3866

1.29

5.10

5.7

4.4

0.00

estimate

0.69

191

1271

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

116

2.53

5.05

1.3

—

(3000012) Reticulocyte production index

239

2.04

5.02

2.4

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1440

13603

1.34

4.94

26.4

14.6

77.16

75.42

ml/min/173m2

2.45

1284

11244

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1586

15228

1.46

4.84

16.7

11.0

24.04

24.66

u/l

0.83

1559

14600

(3000570) Elastase.pancreatic [Mass/mass] in Stool

469

1.69

4.56

1.3

1.4

296.48

279.50

ug/g

0.33

263

(3025941) Bacteria identified in Stool by Culture

112

737

1.56

4.56

1.3

—

(40768443) Skin Pathology biopsy report

102

657

1.59

4.55

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

154

2.23

4.54

1.4

1.2

269.55

274.89

mosm/kgh2o

0.62

114

(3008757) Leukocyte morphology finding [Identifier] in Blood

174

2.15

4.52

4.6

4.8

—

(3004616) Nuclear Ab [Presence] in Serum

174

2.15

4.52

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

6.70

4.47

1.2

1.0

5.04

8.02

u/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

396

1.75

4.46

3.9

3.2

0.82

0.81

nmol/l

0.08

303

(3041096) Erythrocytes [Presence] in Urine by Automated

446

3715

1.27

4.38

4.4

3.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

467

1.68

4.37

5.1

3.7

3.88

3.90

mmol/l

0.20

461

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

170

2.14

4.36

1.2

2.67

5.92

u/ml

1.08

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

124

845

1.50

4.31

3.3

3.2

4.20

4.39

pmol/l

1.86

109

736

(1002224) Polysomnography panel

408

1.72

4.30

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.53

4.29

1.5

2.0

—

(3050794) Legionella sp Ab [Presence] in Serum

6.95

4.16

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.47

4.05

1.8

1.6

6.05

6.87

u/l

0.06

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

444

3731

1.25

4.00

2.9

2.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

143

2.19

4.00

1.3

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

181

1347

1.38

3.94

3.8

3.6

1.22

1.23

mmol/l

1.33

167

1148

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

164

2.09

3.93

1.1

—

(3017704) Immunofixation for Urine

107

2.36

3.84

1.2

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

159

2.10

3.83

3.8

4.0

58.68

55.10

0.63

138

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

407

3410

1.25

3.74

1.7

18475562.27

18630370.24

pmol/l

0.00

341

2759

(3045716) Anion gap in Serum or Plasma

2.70

3.66

1.7

1.9

9.28

9.86

mmol/l

0.29

(3044640) Blood type and Crossmatch panel - Blood

557

4837

1.22

3.66

3.0

2.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

104

709

1.50

3.65

4.6

3.6

49.27

47.96

0.21

104

699

(3002523) Influenza virus A Ag [Presence] in Specimen

143

2.12

3.60

1.3

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.76

3.59

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.25

3.50

1.5

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

613

5396

1.21

3.47

5.3

4.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.49

3.47

1.9

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

119

2.20

3.45

1.1

—

43.43

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.46

3.38

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.02

3.37

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

101

2.29

3.36

5.7

2.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.76

3.24

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.76

3.24

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.76

3.24

1.4

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

230

1.80

3.13

2.9

2.4

26.53

26.23

mg/l

0.02

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.52

3.11

1.6

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.81

3.09

3.3

2.5

44850.36

39374.00

ug/l

0.38

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.68

3.08

2.3

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

3.19

3.05

4.3

6.6

26.69

24.96

mmol/l

0.98

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

7.52

3.05

1.3

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

481

1.54

3.05

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.27

3.03

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

133

2.05

3.02

1.1

1.3

—

30.44

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

427

1.57

2.99

1.5

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

163

1250

1.34

2.97

1.6

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.25

2.97

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.25

2.97

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.25

2.97

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.65

2.96

1.2

—

0.43

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

156

1192

1.34

2.92

2.5

2.6

65.74

62.42

ml/min/173m2

0.54

505

(3042733) HLA Ab [Presence] in Serum

3.45

2.90

4.2

3.7

—

(3034426) Prothrombin time (PT)

3.45

2.90

1.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

5.40

2.87

1.4

1.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.68

2.87

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.68

2.87

1.2

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

165

1.89

2.81

1.5

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

165

1.89

2.81

2.6

2.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

767

6984

1.18

2.81

3.0

2.6

—

(3014271) Vancomycin [Susceptibility]

2.24

2.80

3.5

2.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.59

2.78

1.2

1.0

0.57

0.02

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

106

769

1.40

2.75

2.2

2.1

14.23

12.39

nmol/l

1.31

674

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.25

2.72

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.25

2.72

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.25

2.72

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.25

2.72

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.61

2.70

1.4

1.3

140.07

159.98

mmol/24h

0.39

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.02

2.70

1.2

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.46

2.69

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

118

876

1.37

2.68

2.6

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

154

1.90

2.66

1.3

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.47

2.62

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.16

2.61

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.16

2.61

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.35

2.60

4.7

6.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

123

924

1.36

2.60

2.4

2.5

8.41

26.37

au/ml

—

(3008898) HLA-B27 [Presence]

346

1.58

2.59

1.1

—

(1761868) Lipid panel - Serum or Plasma

382

4393

0.83

2.56

3.0

3.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

5.47

2.54

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

157

1.86

2.53

1.5

1.3

—

nmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.24

2.52

1.1

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.39

2.47

2.4

1.6

—

(3045142) Bone marrow Pathology biopsy report

197

1.74

2.40

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.35

2.39

1.4

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

6.26

2.37

1.0

0.02

0.24

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

362

1.54

2.37

1.6

7029.13

13259.46

e6/l

1.31

267

(3009542) Hematocrit [Volume Fraction] of Blood

1604

15667

1.29

2.28

44.9

22.8

39.55

39.40

0.45

1489

14493

(3012516) Albumin [Mass/volume] in Urine

523

4682

1.17

2.27

3.2

947.46

362.00

mg/l

1.13

317

2895

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

113

1.96

2.25

2.2

—

(3007461) Platelets [#/volume] in Blood

1604

15672

1.29

2.24

44.7

22.7

270.33

246.88

e9/l

29.12

1587

15222

(3010838) Calcium [Moles/time] in 24 hour Urine

287

1.58

2.23

2.3

1.8

4.26

4.62

mmol/24h

0.38

242

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.57

2.21

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.87

2.21

4.7

6.1

—

(3024731) MCV [Entitic volume]

1604

15676

1.29

2.20

44.5

22.7

91.61

91.54

0.26

1595

15404

(3035941) MCH [Entitic mass]

1604

15677

1.29

2.19

44.4

22.6

30.13

30.39

6.59

1595

15403

(3009508) Creatinine [Moles/volume] in Urine

534

4801

1.16

2.18

3.1

6.50

6.99

mmol/l

2.06

454

3975

(3026361) Erythrocytes [#/volume] in Blood

1604

15678

1.29

2.18

44.7

22.7

4.39

4.41

e12/l

0.97

1588

15166

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

173

1.75

2.17

2.2

1.6

—

(3010813) Leukocytes [#/volume] in Blood

1604

15679

1.28

2.17

44.7

22.7

7.80

6.69

e9/l

36.61

1588

15169

(3038177) Helicobacter pylori Ab [Presence] in Serum

181

1.73

2.16

1.1

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1604

15681

1.28

2.15

45.0

22.9

130.79

133.08

g/l

8.56

1595

15407

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

4.30

2.15

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.30

2.15

1.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

2.79

2.14

1.2

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

130

1.86

2.12

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

228

1.64

2.12

1.9

1.3

107.55

129.57

u/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

182

1.72

2.12

1.5

1.3

—

0.48

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

719

1.35

2.11

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

107

815

1.33

2.11

1.5

1.3

—

(3023410) Appearance of Cerebral spinal fluid

131

1.84

2.08

1.2

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.71

2.07

1.7

1.5

0.12

0.52

ug/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

302

1.54

2.04

1.4

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.01

2.04

1.0

1.3

—

(3044927) Protein electrophoresis panel - Urine

192

1.68

2.03

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

417

1.45

2.03

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.12

2.02

1.3

1.2

153.50

140.24

nmol/l

0.50

(1617658) Protocol used for examination of sentinel lymph nodes

148

0.34

2.00

1.2

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

171

1.71

1.97

1.4

1.5

52.57

62.31

0.65

113

(3014765) Yersinia sp identified in Stool by Organism specific culture

422

1.44

1.93

1.3

1.2

—

(3019977) pH of Arterial blood

2.06

1.91

2.3

2.9

7.44

7.41

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

121

1.83

1.88

1.3

1.5

21.60

19.19

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.87

1.86

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

301

1.51

1.86

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

213

1.61

1.86

1.5

1.2

226.86

280.35

u/ml

0.57

122

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.40

1.85

1.2

1.3

318.83

634.88

ug/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

426

1.42

1.84

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

214

1.60

1.83

1.1

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

4.18

1.82

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.05

1.80

5.9

7.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.35

1.77

1.2

38.34

37.37

g/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

445

4007

1.15

1.75

1.6

1.35

1.32

mmol/l

0.09

372

3306

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

209

1.59

1.74

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

217

1.58

1.74

1.7

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

105

824

1.29

1.72

1.2

67.94

138.65

iu/ml

2.17

306

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.85

1.71

4.8

5.2

—

(3019150) Specific gravity of Urine by Refractometry

353

3137

1.16

1.66

5.6

4.5

1.02

kg/l

0.46

495

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

228

1.55

1.65

1.4

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.11

1.65

1.3

1.2

1.06

1.07

ratio

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

167

1393

1.22

1.63

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

213

1.56

1.63

1.7

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

254

1.51

1.61

1.9

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

209

1785

1.19

1.60

3.0

4.0

3.97

20.66

ug/l

2.82

184

1462

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

214

1.55

1.60

1.8

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

214

1.55

1.60

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

214

1.55

1.60

1.7

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

183

1.59

1.57

1.9

2.3

—

(3002256) Pathology report gross observation

225

1938

1.18

1.57

1.3

—

(3000330) Specific gravity of Urine by Test strip

852

0.74

1.57

4.6

3.7

—

(40768793) Breast Pathology biopsy report

407

0.63

1.53

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.60

1.51

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.60

1.51

1.1

1.2

—

(3019225) pH of Specimen

200

1712

1.19

1.50

4.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.51

1.45

1.7

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

3.13

1.44

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.13

1.44

1.4

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1391

13524

1.14

1.43

6.3

6.1

40.71

40.31

mmol/mol

0.93

1296

12291

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.73

1.43

1.2

1.1

—

(3024932) HLA-DR beta [Type]

2.31

1.43

1.2

1.1

—

(3024471) HLA-A [Type]

2.26

1.40

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

846

0.76

1.39

1.5

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.08

1.38

1.8

1.2

18.23

13.90

g/l

—

(3037121) Protein [Mass/volume] in Urine

558

1.30

1.35

2.6

2.9

0.27

0.29

g/l

0.07

204

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

159

1.58

1.34

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.2

—

2.47

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.97

1.33

1.4

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.31

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

217

1.48

1.31

1.8

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

448

0.69

1.28

4.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.09

1.27

3.8

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.79

1.27

2.1

2.5

—

(40761536) Microorganisms panel - Urine sediment

149

1265

1.19

1.26

5.5

4.2

—

(21494434) Karyotype in Bone marrow

162

1.55

1.26

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

286

1.41

1.26

2.0

2.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.40

1.24

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

330

1.37

1.23

2.4

2.9

31.31

33.97

umol/l

0.35

296

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.91

1.23

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

335

3689

0.89

1.21

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

2.31

1.18

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.11

1.18

1.0

1.5

82.88

95.87

nmol/24h

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.78

1.17

2.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

326

1.36

1.14

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

397

1.32

1.12

1.3

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

1.12

2.5

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

328

1.35

1.11

1.4

1.3

38.51

34.37

iu/l

0.27

284

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.19

1.08

1.3

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

113

1.60

1.05

2.6

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

1.61

1.03

1.8

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.84

1.03

1.5

2.4

—

(40761535) Cells panel - Urine sediment

147

1273

1.17

1.02

4.9

3.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

527

4936

1.10

1.02

3.7

3.8

8.01

8.33

mg/mmol

0.06

308

3005

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.77

1.00

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

1.00

1.0

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.67

0.98

1.4

5.37

5.96

u/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

140

1.51

0.97

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

456

0.74

0.96

2.1

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

149

1.48

0.95

1.7

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.69

0.95

2.2

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.77

0.94

1.3

1.2

131.76

171.20

pmol/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.90

0.94

1.3

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.67

0.91

2.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.15

0.91

2.5

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

126

1.51

0.91

1.5

1.2

—

(40768446) Kidney Pathology biopsy report

1.91

0.88

1.9

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.58

0.87

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

604

1.22

0.87

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

724

0.81

0.86

1.3

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.76

0.83

3.0

2.1

—

(4035726) Immunohistochemistry procedure

162

1441

1.14

0.82

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1.58

0.81

2.1

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

185

2055

0.89

0.81

4.3

4.7

36.28

33.15

3.41

137

1328

(3013139) Helicobacter pylori Ag [Presence] in Stool

111

963

1.16

0.80

1.4

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.82

0.79

2.7

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

366

1.26

0.79

2.7

3.4

431.43

1089.38

u/ml

0.42

337

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

106

1.51

0.79

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

148

1.42

0.78

1.2

1.0

2.34

2.39

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

162

0.62

0.77

1.1

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.60

0.75

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

325

1.27

0.73

1.5

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

139

1235

1.14

0.73

1.5

1.8

1.74

1.51

1.07

119

1041

(3019897) Erythrocyte distribution width [Ratio] by Automated count

107

0.56

0.72

20.3

2.6

13.67

13.20

—

107

(3045424) Erythrocytes [Presence] in Urine

238

1.31

0.71

1.7

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.93

0.70

1.2

1.4

117.60

91.97

ng/l

—

(3013512) EKG study

504

4789

1.07

0.68

5.4

4.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.53

0.66

1.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.53

0.66

1.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.53

0.66

1.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.53

0.66

1.0

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

430

1.22

0.66

1.9

1.7

10.32

2.89

mg/l

2.15

330

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

111

1.45

0.66

2.5

2.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

206

1.32

0.65

1.3

15.11

10.99

u/l

0.43

159

(3006442) Creatine [Moles/volume] in Serum or Plasma

103

1.46

0.65

1.2

1.4

82.67

87.24

umol/l

0.20

103

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

404

0.79

0.64

1.4

—

(3014891) Appearance of Pleural fluid

1.73

0.64

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.62

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

270

1.26

0.62

1.3

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

315

1.24

0.62

1.3

1.4

7.70

35.35

e6/l

0.82

250

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

102

0.59

0.62

1.0

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

316

1.24

0.61

1.4

1544.00

528.65

e6/l

0.37

266

(3047189) Immunofixation for 24 hour Urine

1.48

0.60

2.2

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

185

2016

0.91

0.60

11.9

7.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

209

1.30

0.60

1.6

1.1

—

(3048879) Bone marrow aspiration report

1.57

0.60

3.4

1.6

—

(3044007) Cell count panel - Peritoneal fluid

1.57

0.60

2.0

1.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

2.2

—

1.63

—

(3039443) Prostate specific Ag panel - Serum or Plasma

186

0.70

0.59

1.2

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.57

0.58

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

140

1.36

0.58

1.6

1.3

15430.60

84108.49

e6/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.58

0.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.72

0.57

1.2

3.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

330

0.78

0.56

1.7

1.5

90.50

206.05

pmol/l

2.01

323

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.51

0.56

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.51

0.56

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.62

0.55

1.5

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.62

0.55

1.3

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

1.41

0.55

1.1

1.6

14.01

13.86

umol/l

0.02

(3000093) Morphology [Interpretation] in Blood Narrative

133

1.36

0.55

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.58

0.54

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

276

1.24

0.54

1.2

1.4

—

(4281824) Cell count and differential, peritoneal fluid

193

0.72

0.53

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

566

0.84

0.53

1.5

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

387

1.19

0.52

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

250

1.24

0.52

1.8

1.7

255.38

302.29

mu/l

0.66

228

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.42

0.50

1.7

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.46

0.50

1.7

1.4

7.48

9.50

ug/l

—

(3029075) Extractable nuclear Ab panel - Serum

1.46

0.50

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.50

0.49

1.9

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.41

0.47

2.1

1.8

—

(3025130) Human papilloma virus identified in Specimen

120

1.34

0.46

1.9

—

(3005033) Fetal Nuchal fold Thickness US

0.62

0.45

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.62

0.45

1.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.60

0.45

1.0

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.43

0.45

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

414

1.16

0.43

1.3

1.6

—

(3011288) Drugs identified in Urine by Screen method

139

1.30

0.43

2.1

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

339

0.82

0.43

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1431

14153

1.06

0.42

5.2

4.9

5.89

6.01

mmol/l

2.70

1322

12635

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.56

0.42

1.2

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1367

13506

1.06

0.41

4.2

4.1

1.23

1.28

mmol/l

2.36

1227

12037

(40765096) Chromosome analysis panel by Banding

1.38

0.41

1.5

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.52

0.41

2.0

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.47

0.40

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

150

1.27

0.40

1.8

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

635

1.12

0.40

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.31

0.39

1.4

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.39

0.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.39

0.38

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

336

1.16

0.37

1.8

1.9

5.26

4.74

iu/l

0.08

115

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

451

4354

1.05

0.37

5.1

5.3

2.23

4.57

ug/l

1.50

397

3858

(40768795) Lymph node Pathology biopsy report

161

1.25

0.37

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.39

0.37

1.3

1.7

—

(3024263) Appearance of Synovial fluid

1.36

0.36

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

0.66

0.35

3.6

4.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.65

0.35

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

211

0.80

0.34

3.2

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.31

0.33

4.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.31

0.33

4.0

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

285

0.84

0.32

1.3

1.5

0.91

0.78

nmol/l

0.72

236

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

362

3489

1.05

0.32

4.7

4.6

18.75

21.54

3.07

158

1821

(3044941) Cell count panel - Synovial fluid

249

1.17

0.30

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

120

1.25

0.30

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

111

1.26

0.30

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

157

1.21

0.29

2.0

1.9

14135.43

2558.26

u/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

0.75

0.29

1.3

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.32

0.28

1.0

1.1

44.40

27.63

u/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

171

0.82

0.26

2.2

2.4

0.60

1.56

g/24h

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.25

0.25

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

133

1.20

0.24

1.2

2.2

1.38

2.10

u/field

—

(3016879) Cocaine [Presence] in Urine

189

1.17

0.24

1.8

1.5

—

(4034850) Laboratory test

456

1.10

0.23

12.5

11.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

247

1.14

0.22

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

314

1.12

0.22

1.4

1.2

3.75

3.80

mmol/l

0.17

298

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

1.22

0.21

1.2

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

3.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

315

1.11

0.21

1.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.3

—

1.58

—

(3015183) Erythrocyte sedimentation rate

1.16

0.21

1.0

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.20

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

197

0.86

0.19

2.6

2.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

607

1.07

0.19

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

154

0.84

0.19

1.4

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

377

1.09

0.18

2.6

2.3

120.39

78.44

ug/min

0.32

216

(3049717) Cytology report of Urine Cyto stain

622

1.06

0.16

2.3

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1452

14449

1.03

0.16

5.3

2.55

2.69

mmol/l

6.63

1338

13021

(3016650) Hepatitis A virus Ab [Presence] in Serum

204

0.88

0.16

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.13

0.16

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.75

0.15

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.21

0.15

1.2

1.0

—

(3004451) EKG impression Narrative

1.21

0.15

2.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

431

0.93

0.15

3.1

2.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.14

0.15

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.14

0.15

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

199

1.11

0.13

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.17

0.13

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.17

0.13

1.1

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

256

2505

1.03

0.13

3.1

3.3

0.58

0.79

ug/l

6.75

170

1765

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

134

1381

0.97

0.12

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

261

0.92

0.11

1.2

1.3

114.67

216.57

miu/ml

—

108

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1404

13984

1.02

0.11

4.7

4.6

1.53

1.49

mmol/l

2.21

1281

12583

(3016018) Differential panel - Cerebral spinal fluid

134

1.12

0.11

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

202

1.09

0.10

1.8

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1416

14110

1.02

0.10

4.8

4.7

4.50

4.61

mmol/l

3.51

1299

12800

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.06

0.09

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.06

0.09

1.8

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

401

0.95

0.09

1.4

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

613

0.96

0.08

2.0

1.7

—

(3045414) Leukocytes [Presence] in Urine

677

1.04

0.08

2.3

2.0

—

(3028300) Cannabinoids [Presence] in Urine

205

1.07

0.08

1.8

1.4

—

(3027008) Opiates [Presence] in Urine

205

1.07

0.08

1.8

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.11

0.05

4.4

5.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

344

0.96

0.05

5.8

3.6

29.58

26.31

mg/l

0.23

212

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

120

1.08

0.05

1.1

1.2

2.07

1.47

nmol/l

0.87

107

(40768441) Liver Pathology biopsy report

112

1.07

0.03

1.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

681

0.98

0.02

2.1

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

200

2012

0.99

0.02

1.4

—

(3025577) Chromium [Mass/volume] in Blood

103

1.07

0.02

2.4

2.0

1.63

1.93

ug/l

0.35

(3022621) pH of Urine by Test strip

107

1062

1.01

0.01

3.8

3.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

126

0.95

0.00

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

216

0.97

0.00

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.05

0.00

2.3

2.4

—

(40768800) Prostate Pathology biopsy report

299

1.00

0.00

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

615

1.01

0.00

2.3

3.2

97.82

6513.28

u/ml

0.81

524

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

124

0.97

0.00

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

112

0.98

0.00

1.0

306.00

326.73

ng/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

108

1.02

0.00

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

107

1.03

0.00

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

113

0.97

0.00

1.0

1015.50

669.28

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

113

0.97

0.00

1.0

43.83

46.67

ng/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

5.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.63

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.94

0.00

1.0

1.2

—

13.40

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.91

0.00

1.0

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

211.18

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.96

-0.00

8.5

15.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.2

—

376.60

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

3.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

14.06

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.68

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.2

—

19.48

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.90

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.00

-0.00

1.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.95

-0.00

7.5

3.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.6

—

3.18

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.87

-0.00

2.2

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.95

-0.00

1.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_OPPORTUNIST_INFECTIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_OPPORTUNIST_INFECTIONS	1.696 [1.51, 1.91]	< 0.001
Birth year	0.994 [0.98, 1.01]	0.305

During the follow-up period (1.1.1998 — 31.12.2019), 996 out of 3792 females with ASTHMA_OPPORTUNIST_INFECTIONS died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_OPPORTUNIST_INFECTIONS	1.784 [1.56, 2.04]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 952 out of 2501 males with ASTHMA_OPPORTUNIST_INFECTIONS died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_OPPORTUNIST_INFECTIONS.

N-year risk	Females	Males
1	0.117%	0.382%
5	0.809%	2.183%
10	2.403%	5.354%
15	5.126%	10.554%
20	8.776%	16.998%

Relationships between endpoints

↥

Index endpoint: ASTHMA_OPPORTUNIST_INFECTIONS – Asthma and opportunity respiratory infection

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Asthma and opportunity respiratory infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints